https://www.pharmaceutical-business-review.com/news/ocular-therapeutix-announces-topline-results-of-phase-3-trial-of-dextenza-for-treatment-of-ocular-itching-associated-with-allergic-conjunctivitis/attachment/lab-3498584_640-1/ 2020-04-29T11:07:25+00:00 https://www.pharmaceutical-business-review.com/news/gilead-remdesivir/attachment/gileadcovid/ 2020-04-30T10:24:20+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-incytes-pemazyre-as-first-targeted-treatment-for-adults-with-previously-treated-unresectable-locally-advanced-or-metastatic-cholangiocarcinoma/attachment/fda-drug-5/ 2020-04-30T11:06:29+00:00 https://www.pharmaceutical-business-review.com/news/catalent-signs-agreement-with-johnson-johnson-to-be-us-manufacturing-partner-for-lead-covid-19-vaccine-candidate/attachment/ccc/ 2020-04-30T11:50:02+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-oxford-university-covid-19/attachment/astravirus/ 2020-05-01T08:58:58+00:00 https://www.pharmaceutical-business-review.com/news/moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine-against-novel-coronavirus/attachment/corvirus-2/ 2020-05-01T10:15:44+00:00 https://www.pharmaceutical-business-review.com/news/canada-abcellera-covid-19/attachment/covidvirus/ 2020-05-04T08:49:23+00:00 https://www.pharmaceutical-business-review.com/news/gilead-remdesivir-eua-covid-19/attachment/coronavirus-4972480_640-4/ 2020-05-04T10:31:40+00:00 https://www.pharmaceutical-business-review.com/news/novartis-receives-chmp-positive-opinion-for-enerzair-breezhaler/attachment/novartis-4/ 2020-05-04T11:20:36+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-junshi-covid-19/attachment/junishi/ 2020-05-05T08:11:33+00:00 https://www.pharmaceutical-business-review.com/news/arcturus-therapeutics-catalent-announce-partnership-to-manufacture-mrna-based-covid-19-vaccine/attachment/catalent-2/ 2020-05-05T10:50:12+00:00 https://www.pharmaceutical-business-review.com/news/vir-2703-covid-19-rnai-therapeutic/attachment/covid-19-4982910_640-4/ 2020-05-05T11:06:52+00:00 https://www.pharmaceutical-business-review.com/news/acceleron-receives-prime-designation-from-ema-for-sotatercept-in-pulmonary-arterial-hypertension/attachment/laboratory-3827745_640-2-2/ 2020-05-05T11:13:39+00:00 https://www.pharmaceutical-business-review.com/news/alexion-portola-biopharmaceutical/attachment/alexion-3/ 2020-05-06T08:31:38+00:00 https://www.pharmaceutical-business-review.com/news/lineage-cell-therapeutics-to-apply-allogeneic-dendritic-cell-therapy-programme-to-covid-19-vaccine-development/attachment/corden/ 2020-05-06T09:26:31+00:00 https://www.pharmaceutical-business-review.com/news/covid-19-vaccine-candidate-bnt162-trial/attachment/pfizerworldheadquartersentrance-13/ 2020-05-06T10:56:59+00:00 https://www.pharmaceutical-business-review.com/news/bicycle-therapeutics-announces-first-patient-dosed-in-phase-i-dose-escalation-of-bt5528-in-combination-with-nivolumab/attachment/blood-20745_640-1/ 2020-05-06T11:04:48+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/alkyne-containing-linkers/attachment/wp_11-05/ 2020-05-06T12:14:45+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/alkyne-containing-linkers/attachment/wp_25-05/ 2020-05-06T12:14:50+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/s-clinica-logo/ 2020-05-06T13:54:06+00:00 https://www.pharmaceutical-business-review.com/news/novartis-tabrecta-nsclc/attachment/novarbuilding-2/ 2020-05-07T09:09:20+00:00 https://www.pharmaceutical-business-review.com/news/twist-bioscience-identifies-competitive-antibodies-for-sars-cov-2/attachment/twist/ 2020-05-07T11:05:24+00:00 https://www.pharmaceutical-business-review.com/news/laurent-pharmaceuticals-receives-health-canadas-approval-to-initiate-covid-19-clinical-trial/attachment/coronavirus-4972480_640-6/ 2020-05-07T11:19:00+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/quality-system-staff-reduction/attachment/nsf-ph-white-paper-managing-a-quality-system-with-50-staff-reduction/ 2020-05-07T11:45:37+00:00 https://www.pharmaceutical-business-review.com/news/zyus-vido-intervac/attachment/covid-19-disease/ 2020-05-08T08:17:06+00:00 https://www.pharmaceutical-business-review.com/news/certara-and-dmtc-announce-research-collaboration-to-study-preventative-use-of-chloroquine-in-health-care-workers-at-high-risk-for-covid-19/attachment/stbt/ 2020-05-08T10:07:33+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-submits-snda-for-trastuzumab-deruxtecan-in-japan-for-her2-positive-metastatic-gastric-cancer/attachment/cancer-cells-541954_640-2/ 2020-05-08T10:57:34+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-daiichi-sankyo-enhertu/attachment/drug-15/ 2020-05-11T08:31:08+00:00 https://www.pharmaceutical-business-review.com/news/lilly-receives-us-fda-approval-for-retevmo/attachment/eli-lilly-5/ 2020-05-11T10:43:08+00:00 https://www.pharmaceutical-business-review.com/news/jcyte-santen-jcell-deal/attachment/1200px-santen_pharmaceutical_co-_ltd-_nara_rd_center_3/ 2020-05-11T11:27:30+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/s_clinica_2011_4q_baseclair_ok/ 2020-05-11T13:37:22+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/s_clinica_horiz_4q_ok/ 2020-05-11T13:38:15+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/image1/ 2020-05-11T14:12:48+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/image2/ 2020-05-11T14:12:56+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/image3/ 2020-05-11T14:13:13+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/image1-2/ 2020-05-11T14:28:35+00:00 https://www.pharmaceutical-business-review.com/news/india-glenmark-covid-19/attachment/glenmark/ 2020-05-12T08:23:42+00:00 https://www.pharmaceutical-business-review.com/news/crispr-therapeutics-and-vertex-pharmaceuticals-announce-fda-rmat-designation-granted-to-ctx001-to-treat-severe-hemoglobinopathies/attachment/fda-drug-6/ 2020-05-12T10:00:31+00:00 https://www.pharmaceutical-business-review.com/news/acer-therapeutics-emetine-covid-19/attachment/covid-19-4982910_640-5/ 2020-05-12T10:04:13+00:00 https://www.pharmaceutical-business-review.com/news/appili-therapeutics-submits-cta-with-health-canada-to-sponsor-trial-of-favipiravir-as-preventative-measure-against-covid-19/attachment/covid-19-4961257_640-8/ 2020-05-12T10:11:10+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/storefront_mainimage/ 2020-05-13T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/moderna-mrna-vaccine/attachment/coronamoderna/ 2020-05-13T08:28:23+00:00 https://www.pharmaceutical-business-review.com/news/ocular-therapeutix-announces-first-patient-dosed-in-phase-1-clinical-trial-of-otx-csi-to-treat-dry-eye-disease/attachment/eye/ 2020-05-13T09:51:01+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/storefront_mainimage2/ 2020-05-13T11:07:44+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-sarclisa-ikema-trial/attachment/1200px-sanofi_frankfurt_iph/ 2020-05-13T11:15:51+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-gets-approval-of-tukysa-in-switzerland-for-metastatic-her2-positive-breast-cancer/attachment/cancer-cells-541954_640-1/ 2020-05-13T11:21:44+00:00 https://www.pharmaceutical-business-review.com/news/catalent-ennaid-therapeutics-covid-19/attachment/covid-disease/ 2020-05-14T08:56:12+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-collaborates-with-cdr-life-to-develop-antibody-fragment-based-therapeutics-for-geographic-atrophy/attachment/geography/ 2020-05-14T10:37:30+00:00 https://www.pharmaceutical-business-review.com/news/cipla-enters-into-a-licensing-agreement-with-gilead-to-expand-access-to-covid-19-treatment/attachment/coronavirus-4972480_640-7/ 2020-05-14T11:18:43+00:00 https://www.pharmaceutical-business-review.com/news/takeda-lymphoma-adcetris/attachment/takeda-7/ 2020-05-15T08:09:50+00:00 https://www.pharmaceutical-business-review.com/news/neuraptive-therapeutics-announces-fda-has-granted-fast-track-designation-to-ntx-001-clinical-development-programme-to-treat-peripheral-nerve-injuries/attachment/fda-drug-7/ 2020-05-15T09:58:09+00:00 https://www.pharmaceutical-business-review.com/news/nantkwest-and-immunitybio-to-initiate-a-phase-2-study-of-immunotherapy-for-metastatic-pancreatic-cancer/attachment/science-1336663_640-2-2/ 2020-05-15T10:53:35+00:00 https://www.pharmaceutical-business-review.com/news/deciphera-qinlock-gastrointestinal/attachment/fda-drug-8/ 2020-05-18T08:39:03+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-announces-pre-ind-submission-to-us-fda-for-piclidenoson-in-treatment-of-covid-19-infected-patients-with-moderate-to-severe-symptoms/attachment/pr-ind/ 2020-05-18T10:10:32+00:00 https://www.pharmaceutical-business-review.com/news/moderna-covid-19-vaccine/attachment/moderna-2/ 2020-05-19T08:35:37+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-genentechs-tecentriq-as-first-line-monotherapy-for-certain-people-with-metastatic-nsclc/attachment/fda-drug-9/ 2020-05-19T10:29:17+00:00 https://www.pharmaceutical-business-review.com/news/novartis-avexis-gets-zolgensma/attachment/novarbuilding-3/ 2020-05-20T08:26:46+00:00 https://www.pharmaceutical-business-review.com/news/tolero-pharmaceuticals-submits-investigational-new-drug-application-for-experimental-pkm2-activator-tp-1454/attachment/fda-drug-10/ 2020-05-20T10:05:19+00:00 https://www.pharmaceutical-business-review.com/news/rallybio-series-b-round/attachment/science-1029385_640-1/ 2020-05-20T11:14:03+00:00 https://www.pharmaceutical-business-review.com/news/janssen-announces-phase-1-results-for-amivantamab-in-advanced-nsclc-harbouring-exon-20-insertion-mutations/attachment/laboratory-3827745_640-3/ 2020-05-20T11:21:58+00:00 https://www.pharmaceutical-business-review.com/suppliers/sofgen-cdmo/attachment/softigel-logo/ 2020-05-20T13:07:45+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-usa-ind-covid-19/attachment/octapharma/ 2020-05-21T08:47:35+00:00 https://www.pharmaceutical-business-review.com/news/lynparza-approved-in-us-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/attachment/fda-drug-11/ 2020-05-21T09:29:04+00:00 https://www.pharmaceutical-business-review.com/news/gilead-and-galapagos-announce-positive-topline-results-of-phase-2b-3-trial-of-filgotinib-in-moderately-to-severely-active-ulcerative-colitis/attachment/test-214185_640-6/ 2020-05-21T11:14:25+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/live-instructor-training/attachment/17639957-female-office-worker-typing-on-the-keyboard-2/ 2020-05-21T13:41:14+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-kynmobi-parkinsons/attachment/kynobi/ 2020-05-22T08:05:09+00:00 https://www.pharmaceutical-business-review.com/news/nautilus-biotechnology-raises-76m-in-series-b-funding-to-be-first-to-quantify-human-proteome/attachment/nautis/ 2020-05-22T10:42:08+00:00 https://www.pharmaceutical-business-review.com/news/appili-therapeutics-favipiravir-canada-trial/attachment/covid-19-4922384_640-10/ 2020-05-22T11:14:18+00:00 https://www.pharmaceutical-business-review.com/news/antisense-atl1102-final-phase-2-dmd-results-meet-primary-endpoint-and-exceed-expectations-on-secondary-endpoints/attachment/science-1336663_640-3/ 2020-05-22T11:22:31+00:00 https://www.pharmaceutical-business-review.com/news/algernon-ifenprodil-covid-19/attachment/ifendriol/ 2020-05-26T08:48:03+00:00 https://www.pharmaceutical-business-review.com/news/enhertu-granted-orphan-drug-designation-in-us-for-gastric-cancer/attachment/fda-drug-12/ 2020-05-26T09:20:28+00:00 https://www.pharmaceutical-business-review.com/news/novaremed-nrd135s-e1-fda-ind/attachment/lab-3498584_640-2-2/ 2020-05-26T11:28:12+00:00 https://www.pharmaceutical-business-review.com/news/shionogi-tetra-therapeutics/attachment/thermo/ 2020-05-27T08:35:33+00:00 https://www.pharmaceutical-business-review.com/news/merck-themis-bioscience-acquisition/attachment/vaccine-5074670_640/ 2020-05-27T11:23:01+00:00 https://www.pharmaceutical-business-review.com/news/phasebio-vip-receptor-pb1046/attachment/pharmacorona/ 2020-05-28T08:18:14+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-of-nucala-for-patients-with-hypereosinophilic-syndrome/attachment/gsk-8/ 2020-05-28T09:34:22+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-arcus-biosciences-deal/attachment/cancer-cells-541954_640-2-2/ 2020-05-28T12:09:16+00:00 https://www.pharmaceutical-business-review.com/contractors/vetter_pharma_international/news/axia-best-managed-companies-award/attachment/vetter_axia-award-2020/ 2020-05-28T13:11:13+00:00 https://www.pharmaceutical-business-review.com/news/roche-covid-19-pneumonia/attachment/pneumonia/ 2020-05-29T08:15:43+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sab-biotherapeutics-confirms-neutralising-antibodies-to-sars-cov-2-and-begins-clinical-manufacturing-of-novel-covid-19-therapeutic-candidate/attachment/sab/ 2020-05-29T10:32:05+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/attachment/sta_449/ 2020-05-29T12:21:02+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/attachment/dsc_204_f1_phoenix_asc_03/ 2020-05-29T12:21:17+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/attachment/coupling_gc_ms_jeol_tg_209_f1_libra/ 2020-05-29T12:21:58+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/attachment/hfm_446_lambda_medium_06/ 2020-05-29T12:22:32+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/attachment/kinexus_dsr_3d_model/ 2020-05-29T12:22:57+00:00 https://www.pharmaceutical-business-review.com/products/capillary-rheometers/attachment/rosand_rh2000/ 2020-05-29T12:38:33+00:00 https://www.pharmaceutical-business-review.com/news/genentech-tecentriq-avastin-fda/attachment/1210314/ 2020-06-01T06:21:12+00:00 https://www.pharmaceutical-business-review.com/news/remdesivir-simple-trial-results/attachment/covid-19-4982910_640-6/ 2020-06-02T10:05:34+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-heart-disease-brilinta/attachment/medimmune-gaithersburg-us-3/ 2020-06-02T10:24:01+00:00 https://www.pharmaceutical-business-review.com/news/codiak-biosciences-collaborates-with-ragon-institute-to-evaluate-exovacc-vaccine-platform-in-sars-cov-2-and-hiv/attachment/institute/ 2020-06-02T10:33:42+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-dupixent-as-first-biologic-medicine-for-children-aged-six-to-11-years-with-moderate-to-severe-atopic-dermatitis/attachment/fda-drug-13/ 2020-06-02T11:02:24+00:00 https://www.pharmaceutical-business-review.com/news/fsd-pharma-covid-19/attachment/fsd-pharma/ 2020-06-03T08:30:51+00:00 https://www.pharmaceutical-business-review.com/news/agex-therapeutics-imstem-biotechnology-sign-non-binding-letter-of-intent-regarding-investigational-msc-candidate-ims001-for-covid-19/attachment/resume/ 2020-06-03T09:43:33+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-sarclisa-ec-approval/attachment/1200px-sanofi_frankfurt_iph-1/ 2020-06-03T11:39:40+00:00 https://www.pharmaceutical-business-review.com/news/pierre-fabre-braftovi-cetuximab/attachment/ec-building-2/ 2020-06-04T08:39:14+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-usa-extends-funding-for-covid-19-study-following-positive-preliminary-research-data/attachment/octpharm/ 2020-06-04T08:51:26+00:00 https://www.pharmaceutical-business-review.com/news/janssen-jnj-6372-nsclc/attachment/johnson-3/ 2020-06-04T11:05:48+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-accent-cancer/attachment/astra-7/ 2020-06-05T08:27:58+00:00 https://www.pharmaceutical-business-review.com/uncategorized/memo-therapeutics-identifies-potent-sars-cov-2-neutralising-antibodies-from-blood-of-recovered-covid-19-patients/attachment/antibody/ 2020-06-05T09:24:22+00:00 https://www.pharmaceutical-business-review.com/news/cullinan-oncology-completes-98-5m-series-b-financing/attachment/cancer-cells-541954_640-3/ 2020-06-05T10:53:18+00:00 https://www.pharmaceutical-business-review.com/news/janssen-daratumumab-subcutaneous-ec/attachment/darzalex-product-shot-1022x1024/ 2020-06-05T11:20:10+00:00 https://www.pharmaceutical-business-review.com/news/calquence-showed-promising-clinical-improvement-in-majority-of-19-hospitalised-covid-19-patients/attachment/catalyse/ 2020-06-08T09:03:35+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-presents-positive-phase-3-results-from-illuminate-a-study-of-lumasiran/attachment/test-214185_640-7/ 2020-06-08T11:09:32+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-antibody-therapeutic-covid-19/attachment/abbvie-hq-2/ 2020-06-08T11:49:50+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-junshi-covid-19-trial/attachment/junishi-2/ 2020-06-09T08:53:10+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/whitepapers/hipersep/attachment/application-note-hipersep-pilot-answers-new-pharma-requirements-page-d-3/ 2020-06-09T09:33:53+00:00 https://www.pharmaceutical-business-review.com/contractors/actide/news/bio-international-convention/attachment/nubilaria-actide-bio-digital-banner-1110x399-1/ 2020-06-09T09:42:50+00:00 https://www.pharmaceutical-business-review.com/news/relief-therapeutics-and-neurorx-expand-clinical-trial-of-rlf-100-to-all-patients-with-critical-covid-19-and-respiratory-failure/attachment/trial-6/ 2020-06-09T10:53:46+00:00 https://www.pharmaceutical-business-review.com/news/algotherapeutix-announces-orphan-drug-designation-granted-by-fda-for-atx01-in-erythromelalgia/attachment/1200px-erythromelalgia-symptoms/ 2020-06-09T11:01:42+00:00 https://www.pharmaceutical-business-review.com/news/igy-life-sciences-mms-covid-19-antibody/attachment/covid-19-4982910_640-8/ 2020-06-09T11:31:16+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-denmark-biologics-production-facility/attachment/1200px-tokyo_midtown_west/ 2020-06-10T07:41:52+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-ubivac/attachment/bms-facility/ 2020-06-10T10:25:21+00:00 https://www.pharmaceutical-business-review.com/news/lyvgen-announces-clinical-trial-collaboration-with-msd/attachment/lab/ 2020-06-10T10:36:13+00:00 https://www.pharmaceutical-business-review.com/news/autobahn-therapeutics-launches-with-76m-series-b-financing-to-develop-next-generation-therapies-for-cns-disorders/attachment/dollar-2891817_640-1/ 2020-06-10T11:15:04+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/webinar-trial-design/attachment/amarex-webinar-june-16th/ 2020-06-10T16:00:48+00:00 https://www.pharmaceutical-business-review.com/news/vertex-kalydeco-cystic-fibrosis/attachment/ec-building-3/ 2020-06-11T08:26:43+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-announces-positive-top-line-results-from-jade-teen-trial-of-abrocitinib-in-adolescents-with-moderate-to-severe-atopic-dermatitis/attachment/pfizerworld-13/ 2020-06-11T09:54:21+00:00 https://www.pharmaceutical-business-review.com/news/clovis-oncology-completes-target-enrollment-in-athena-trial-in-advanced-ovarian-cancer/attachment/cancer-cells-541954_640-4/ 2020-06-11T11:01:55+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-acquire-corvidia/attachment/image-3/ 2020-06-12T09:34:03+00:00 https://www.pharmaceutical-business-review.com/news/fda-approval-dolutegravir-dispersible-tablet/attachment/hiv-1903372_640-1/ 2020-06-15T06:35:32+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/whitepapers/cannabinoid-purification/attachment/application-note_cannabinoid-purification-and-scale-up_a2/ 2020-06-15T09:48:41+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/whitepapers/elemental-packaging/attachment/application-note_elemental-packing_a3/ 2020-06-15T10:00:16+00:00 https://www.pharmaceutical-business-review.com/suppliers/capsugel/attachment/capsugel-lonza-logos-may-2020_orange-black/ 2020-06-15T13:03:22+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-covid-19-baricitinib/attachment/eli-lilly-6/ 2020-06-16T05:33:32+00:00 https://www.pharmaceutical-business-review.com/news/neoimmunetech-receives-fda-orphan-drug-designation-for-nt-i7-to-treat-progressive-multifocal-leukoencephalopathy/attachment/fda-drug-15/ 2020-06-16T10:02:42+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmamar-zepzelca-fda/attachment/jazz-pharmaceuticals-zepzelca/ 2020-06-16T10:38:06+00:00 https://www.pharmaceutical-business-review.com/news/takeda-neurocrine-psychiatric-disorders/attachment/takeda-8/ 2020-06-17T03:36:45+00:00 https://www.pharmaceutical-business-review.com/news/merck-and-pfizers-sglt2-inhibitor-steglatro-meets-primary-endpoint-in-vertis-cv-trial/attachment/pfizer-17/ 2020-06-17T06:55:16+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-france-vaccines-investment/attachment/injection-5051142_640/ 2020-06-17T11:30:25+00:00 https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-spondyloarthritis/attachment/novartis-5/ 2020-06-18T04:08:57+00:00 https://www.pharmaceutical-business-review.com/news/interdisciplinary-consortium-receives-grant-to-develop-next-generation-cell-based-cancer-vaccines/attachment/optimised/ 2020-06-18T10:36:04+00:00 https://www.pharmaceutical-business-review.com/news/roche-tecentriq-breast-cancer/attachment/roche-9/ 2020-06-19T07:44:59+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-announces-us-fda-accelerated-approval-of-tazverik-for-relapsed-refractory-follicular-lymphoma/attachment/tazverik/ 2020-06-19T11:39:19+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-divest-otc-and-select-non-core-assets-in-asia-pacific-to-celltrion-for-up-to-278m/attachment/takeda-9/ 2020-06-21T18:09:17+00:00 https://www.pharmaceutical-business-review.com/news/covid-19-india-favipiravir-remdesivir/attachment/corona-5174671_640-1/ 2020-06-22T06:26:17+00:00 https://www.pharmaceutical-business-review.com/news/piramal-pharma-solutions-announces-acquisition-of-solid-oral-dosage-drug-product-facility-in-sellersville-pennsylvania-from-gw-laboratories/attachment/pennsylvania-facility/ 2020-06-22T11:11:48+00:00 https://www.pharmaceutical-business-review.com/news/cipla-remdesivir-covid-19/attachment/cipla/ 2020-06-23T03:56:37+00:00 https://www.pharmaceutical-business-review.com/news/merck-v114-phase-3-trials/attachment/laboratory-3827745_640-4/ 2020-06-23T11:10:31+00:00 https://www.pharmaceutical-business-review.com/news/deciphera-announces-health-canadas-authorization-of-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumour/attachment/cancer-cells-541954_640-5/ 2020-06-23T11:19:10+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-pionyr-immunotherapeutics/attachment/gileadscience/ 2020-06-24T01:30:59+00:00 https://www.pharmaceutical-business-review.com/news/frontier-scientific-develops-and-provides-process-to-produce-active-pharmaceutical-ingredient-for-clinical-trial-of-covid-19-therapeutic-investigational-drug-rbt-9/attachment/frontier/ 2020-06-24T10:34:57+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-translate-bio-mrna-vaccines/attachment/medical-5037940_640/ 2020-06-24T11:08:14+00:00 https://www.pharmaceutical-business-review.com/news/novaremed-gets-fda-nod-for-phase-2-trial-of-nrd135s-e1-for-pdpn/attachment/test-214185_640-8/ 2020-06-24T11:19:46+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/new-ivd-app/attachment/nsf_ivd_app_icons_android_512x512/ 2020-06-24T11:40:15+00:00 https://www.pharmaceutical-business-review.com/contractors/cbdepot/news/manufacturing-site-cannabidiol-apis/attachment/cbdepot-2/ 2020-06-24T11:44:12+00:00 https://www.pharmaceutical-business-review.com/news/neurorx-relief-therapeutics-covid-19/attachment/neurotryx/ 2020-06-25T01:23:21+00:00 https://www.pharmaceutical-business-review.com/news/symbiosis-and-astrazeneca-sign-supply-agreement-for-sterile-manufacture-of-covid-19-vaccine-for-clinical-trials/attachment/the-symbiosis-facility-in-stirling-scotland/ 2020-06-25T09:58:22+00:00 https://www.pharmaceutical-business-review.com/news/theravance-biopharma-covid-19/attachment/jaki/ 2020-06-26T03:51:54+00:00 https://www.pharmaceutical-business-review.com/news/merck-recarbrio-habp-vabp/attachment/fda-drug-14/ 2020-06-26T11:05:37+00:00 https://www.pharmaceutical-business-review.com/news/moderna-and-catalent-announce-collaboration-for-fill-finish-manufacturing-of-modernas-covid-19-vaccine-candidate/attachment/cor/ 2020-06-29T00:41:34+00:00 https://www.pharmaceutical-business-review.com/news/carlyle-group-piramal-pharma-deal/attachment/job-4131482_640-19/ 2020-06-29T06:27:23+00:00 https://www.pharmaceutical-business-review.com/news/roche-phesgo-breast-cancer/attachment/basel-1-4/ 2020-06-30T07:08:58+00:00 https://www.pharmaceutical-business-review.com/news/gsk-duvroq-japan-anaemia-ckd/attachment/gsk-londo/ 2020-06-30T11:19:27+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-phase-2a-covid-19-trial-of-nuvoxs-oxygen-therapeutic/attachment/covid-19-4982910_640-9/ 2020-06-30T11:28:03+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-daurismo-leukaemia/attachment/pfizer-18/ 2020-07-01T08:17:13+00:00 https://www.pharmaceutical-business-review.com/news/oncternal-therapeutics-gets-fda-orphan-drug-designations-for-cirmtuzumab-ror1-antibody-to-treat-mcl-and-cll/attachment/fda-drug-17/ 2020-07-01T10:36:50+00:00 https://www.pharmaceutical-business-review.com/news/goldfinch-bio-series-b-round/attachment/job-4131482_640-20/ 2020-07-01T11:28:16+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-initiates-phase-3-trial-of-cabozantinib-atezolizumab-combo-in-prostate-cancer/attachment/test-214185_640-9/ 2020-07-01T11:35:25+00:00 https://www.pharmaceutical-business-review.com/news/janssen-ebola-vaccine-regimen/attachment/ebola/ 2020-07-02T08:29:23+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-announce-early-positive-data-from-sars-cov-2-trial/attachment/coronavirus-3/ 2020-07-02T10:23:35+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-announce-early-positive-data-from-sars-cov-2-trial/attachment/corona-trial/ 2020-07-02T10:24:14+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-expands-ds-1062-study-to-include-patients-with-triple-negative-breast-cancer/attachment/1200px-daiichi_sankyo_nihonbashi_building_at_nihonbashi_chuo_tokyo_2019-01-02_03/ 2020-07-02T11:06:43+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-rukobia/attachment/rukobia/ 2020-07-03T07:41:38+00:00 https://www.pharmaceutical-business-review.com/news/kkr-to-acquire-controlling-stake-in-j-b-chemicals-pharmaceuticals/attachment/jb-pharma/ 2020-07-03T09:14:36+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mercks-keytruda-for-first-line-treatment-of-patients-with-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer/attachment/fda-drug-16/ 2020-07-03T11:22:55+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-veklury/attachment/gilead-5/ 2020-07-06T06:11:56+00:00 https://www.pharmaceutical-business-review.com/news/ascentage-msd-apg-115-keytruda/attachment/keytruda-6/ 2020-07-06T10:40:36+00:00 https://www.pharmaceutical-business-review.com/news/idorsia-announces-positive-results-in-second-phase-3-study-of-daridorexant/attachment/laboratory-3827736_640-1/ 2020-07-06T10:46:51+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-accelerated-assessment-for-trastuzumab-deruxtecan-to-treat-her2-positive-metastatic-breast-cancer/attachment/pill-6/ 2020-07-06T11:06:02+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-covid-19-double-antibody/attachment/covidregeneron/ 2020-07-07T08:07:52+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-covid-19-vaccine-collaboration-with-butantan-receives-approval-from-brazilian-regulator-for-phase-iii-trial/attachment/trial-7/ 2020-07-07T10:05:57+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-sep-4199-bipolar-i-depression/attachment/test-214185_640-10/ 2020-07-07T10:52:49+00:00 https://www.pharmaceutical-business-review.com/news/vrobio-announces-new-patients-dosed-in-gaucher-disease-and-cystinosis-trials/attachment/laboratory-2815631_640/ 2020-07-07T10:58:14+00:00 https://www.pharmaceutical-business-review.com/news/corvus-clinical-trial-immunotherapy/attachment/corvus/ 2020-07-08T07:49:21+00:00 https://www.pharmaceutical-business-review.com/news/ridgeback-eidd-2801-covid-19-phase-2/attachment/agile/ 2020-07-08T10:21:42+00:00 https://www.pharmaceutical-business-review.com/news/vor-biopharma-closes-110m-series-b-financing/attachment/dollar-499481_640/ 2020-07-08T10:27:46+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/benchtop-bioreactor-portfolio/attachment/pro_3-ways-to-optimize-your-benchtop-bioreactor-portfolio/ 2020-07-08T13:04:16+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/in-situ-gas-analyzers/attachment/pro_5-ways-in-situ-gas-analyzers-improve-safety/ 2020-07-08T13:06:02+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/accuracy-do-ph-measurement/attachment/pro_accuracy-guide-hints-and-tips-to-improve-accuracy/ 2020-07-08T13:09:07+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/co2-theory-best-practice/attachment/pro_co2-theory-and-best-practice/ 2020-07-08T13:10:41+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/compliance-design-pharmaceutical-water-systems/attachment/pro_compliance-by-design-in-pharmaceutical-water-systems/ 2020-07-08T13:15:31+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/intelligent-sensors/attachment/pro_greater-process-integrity-with-intelligent-sensors/ 2020-07-08T13:17:45+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/measurement-control-semiconductors/attachment/pro_measurement-control-and-improvement-in-reclaim_recycle_reuse-for-semiconductors/ 2020-07-08T13:20:22+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/maintenance-intelligent-ph-sensor/attachment/pro_monitoring-ph-of-pulp-mill-wastewater/ 2020-07-08T13:22:18+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/optical-do-sensors/attachment/pro_switch-to-optical-do-measurement/ 2020-07-08T13:24:27+00:00 https://www.pharmaceutical-business-review.com/suppliers/ethicheck/attachment/matos-eco-1365-r-g-3/ 2020-07-08T13:55:16+00:00 https://www.pharmaceutical-business-review.com/suppliers/ethicheck/attachment/print-6/ 2020-07-08T13:55:23+00:00 https://www.pharmaceutical-business-review.com/suppliers/ethicheck/attachment/matos-with-hand-1-image-version/ 2020-07-08T13:55:27+00:00 https://www.pharmaceutical-business-review.com/suppliers/ethicheck/attachment/eco-300-glass_for-website/ 2020-07-08T13:55:34+00:00 https://www.pharmaceutical-business-review.com/suppliers/ethicheck/attachment/matos-cloud-150-r/ 2020-07-08T13:55:47+00:00 https://www.pharmaceutical-business-review.com/suppliers/ethicheck/attachment/matos-cloud-250-r/ 2020-07-08T13:55:52+00:00 https://www.pharmaceutical-business-review.com/suppliers/ethicheck/attachment/ethicheck-logo-sept-17/ 2020-07-08T13:56:14+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-lynparza/attachment/astra-8/ 2020-07-09T08:50:15+00:00 https://www.pharmaceutical-business-review.com/contractors/vetter_pharma_international/news/new-site-austria/attachment/vetter%e2%80%affurther-expands-its-development-service%e2%80%afwith-new-site-in-austria-_pic-2/ 2020-07-09T09:45:26+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-neurogenes-gene-therapy-for-treatment-of-cln5-batten-disease/attachment/fda-drug-18/ 2020-07-09T10:53:42+00:00 https://www.pharmaceutical-business-review.com/news/moderna-completes-enrolment-of-phase-2-study-of-its-mrna-vaccine-against-covid-19/attachment/cvid/ 2020-07-09T11:01:17+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/reduce-costs-drug-manufacturing/attachment/easyway_pharmaism_costreduction_en_feb14/ 2020-07-09T15:57:27+00:00 https://www.pharmaceutical-business-review.com/news/noxopharm-reports-covid-19-trial-programme-to-commence-in-europe/attachment/virus-13/ 2020-07-10T03:46:03+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-ntimicrobial-resistance/attachment/pfizer-19/ 2020-07-10T08:27:10+00:00 https://www.pharmaceutical-business-review.com/news/kymera-therapeutics-sanofi-collaborate-to-advance-novel-protein-degrader-therapies-to-patients/attachment/sanofidrug/ 2020-07-10T10:20:48+00:00 https://www.pharmaceutical-business-review.com/news/sechenov-coronavirus-vaccine-candidate-trials/attachment/syringe-417786_640-1/ 2020-07-13T06:47:25+00:00 https://www.pharmaceutical-business-review.com/news/merck-opens-largest-m-lab-collaboration-centre-in-shanghai/attachment/milliporesigma-m-lab-shanghai/ 2020-07-13T11:35:38+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-fda-fast-track-status/attachment/pfizer-20/ 2020-07-14T09:06:31+00:00 https://www.pharmaceutical-business-review.com/news/roche-blueprint-medicines-pralsetinib/attachment/roche-headquarters/ 2020-07-14T10:46:21+00:00 https://www.pharmaceutical-business-review.com/news/rocket-pharmaceuticals-treats-first-patient-in-phase-1-trial-of-rp-l301-for-pkd/attachment/dna-5297378_640/ 2020-07-14T10:53:55+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-commences-1000-patients-post-marketing-surveillance-study-with-covid-19-who-are-administered-fabiflu/attachment/glenmark-2/ 2020-07-14T10:54:01+00:00 https://www.pharmaceutical-business-review.com/news/medicago-covid-19-vaccine/attachment/covid-19-2/ 2020-07-15T09:43:26+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-for-inflazomes-inzomelid-to-treat-cryopyrin-associated-periodic-syndromes/attachment/fda-drug-19/ 2020-07-15T10:22:55+00:00 https://www.pharmaceutical-business-review.com/news/60-degrees-announces-positive-results-of-cell-culture-testing-of-arakoda-for-covid-19/attachment/corona-5174671_640-2/ 2020-07-15T11:01:09+00:00 https://www.pharmaceutical-business-review.com/news/tremfya-eclipse-trial-results/attachment/tremfya/ 2020-07-15T11:38:32+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-nintedanib-ipulmonary-fibrosis/attachment/boehnger-3/ 2020-07-16T08:39:09+00:00 https://www.pharmaceutical-business-review.com/news/us-university-says-common-fda-approved-drug-may-effectively-neutralise-sars-cov-2-virus/attachment/covid-2/ 2020-07-16T11:11:46+00:00 https://www.pharmaceutical-business-review.com/news/bioaegis-therapeutics-receives-approval-to-proceed-with-phase-2-trial-of-its-gelsolin-covid-19-treatment/attachment/genoris/ 2020-07-16T11:56:30+00:00 https://www.pharmaceutical-business-review.com/products/matos-plus-rfid-refrigerator-range/attachment/ethicheck-matos-rfid-refrigeration-range-brochure/ 2020-07-16T13:49:47+00:00 https://www.pharmaceutical-business-review.com/products/matos-plus-aria/attachment/ethicheck-matos-wireless-monitoring-kit-brochure/ 2020-07-16T13:50:02+00:00 https://www.pharmaceutical-business-review.com/news/novartis-not-for-profit-medicines-covid-19/attachment/tower-with-surrounding-buildings-image-4/ 2020-07-17T07:26:19+00:00 https://www.pharmaceutical-business-review.com/news/tonix-announces-collaboration-to-develop-precision-medicine-techniques-for-covid-19-vaccines-and-therapeutics/attachment/vaccine-4946480_640/ 2020-07-17T10:22:30+00:00 https://www.pharmaceutical-business-review.com/news/sinopharm-covid-19-inactivated-vaccine/attachment/he_sheikh_abdullah_bin_mohammed_al_hamed_chairman_of_department_of_health/ 2020-07-20T06:29:10+00:00 https://www.pharmaceutical-business-review.com/news/celltrion-covid-19-antiviral/attachment/cellitron/ 2020-07-20T10:44:15+00:00 https://www.pharmaceutical-business-review.com/news/lillys-mirikizumab-superior-to-cosentyx-in-phase-3-study-for-patients-with-moderate-to-severe-plaque-psoriasis/attachment/lilly-2/ 2020-07-20T10:51:12+00:00 https://www.pharmaceutical-business-review.com/news/adc-therapeutics-begins-phase-2-portion-of-lotis-3-trial-of-lonca-ibrutinibhave-combo/attachment/cancer-cells-541954_640-6/ 2020-07-20T11:05:05+00:00 https://www.pharmaceutical-business-review.com/news/gsk-curevac-mrna-technology/attachment/gsk-house-6/ 2020-07-21T09:06:05+00:00 https://www.pharmaceutical-business-review.com/news/jw-therapeutics-acquires-syracuse-and-license-to-eurekas-solid-tumour-technology-in-china/attachment/handshake-3298455_640-41/ 2020-07-21T10:46:08+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-announce-agreement-with-uk-for-30-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2/attachment/biontech/ 2020-07-21T10:55:43+00:00 https://www.pharmaceutical-business-review.com/casestudies/process-analytical-solutions/attachment/ib_pharmaceutical_en_52900294_mar16/ 2020-07-21T14:32:16+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-tizona-therapeutics/attachment/gilead-6/ 2020-07-22T08:23:26+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-announces-fda-acceptance-of-nda-filing-and-priority-review-for-voclosporin-to-treat-lupus-nephritis/attachment/fda-drug-20/ 2020-07-22T09:38:52+00:00 https://www.pharmaceutical-business-review.com/news/jnana-roche-small-molecule-drugs/attachment/roche-switzerland-headquarters/ 2020-07-22T10:25:57+00:00 https://www.pharmaceutical-business-review.com/news/xylocor-doses-patients-in-phase-1-2-trial-evaluating-xc001-in-refractory-angina/attachment/dna-5297378_640-1/ 2020-07-22T10:32:51+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/incident-investigation-reports/attachment/nsf-ph-white-paper-effective-and-fast-approval-of-incident-reports/ 2020-07-22T14:21:03+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-us-govt/attachment/pfizerworldheadquartersentrance-14/ 2020-07-23T10:48:25+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-gets-us-fda-approval-of-xywav-for-cataplexy-associated-with-narcolepsy/attachment/jazz-pharmaceuticals-xywav/ 2020-07-23T10:58:19+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/whitepapers/software-clairvoyance-structure-reliability/attachment/s-clinica_v2/ 2020-07-23T13:24:25+00:00 https://www.pharmaceutical-business-review.com/news/humanetics-gets-financing-from-niaid-to-study-bio-300-drug-in-covid-19-patients/attachment/humanetics/ 2020-07-24T08:30:17+00:00 https://www.pharmaceutical-business-review.com/news/medidata-supports-modernas-covid-19-vaccine-clinical-trials-with-rave-clinical-cloud-platform/attachment/medi/ 2020-07-24T10:33:22+00:00 https://www.pharmaceutical-business-review.com/news/inotrem-gets-clearance-to-launch-phase-2-trial-of-nangibotide-in-covid-19-patients/attachment/virus-5410598_640-1/ 2020-07-24T11:19:49+00:00 https://www.pharmaceutical-business-review.com/news/novartis-announces-phase-iii-study-of-jakavi-in-chronic-graft-versus-host-disease-met-primary-and-key-secondary-endpoints/attachment/novar-8/ 2020-07-27T00:56:12+00:00 https://www.pharmaceutical-business-review.com/news/gileads-kite-tecartus/attachment/fda-drug-21/ 2020-07-27T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/moderna-announces-expansion-of-barda-agreement-to-support-larger-phase-3-programme-for-covid-19-vaccine/attachment/large-vaccine/ 2020-07-27T10:17:43+00:00 https://www.pharmaceutical-business-review.com/news/azd1222-astrazeneca-oxford-trial/attachment/astrazeneca-headquarters/ 2020-07-27T10:37:39+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-astrazeneca-ds-1062/attachment/astrazeneca-headquarters-2/ 2020-07-27T10:38:16+00:00 https://www.pharmaceutical-business-review.com/news/janssen-darzalex-multiple-myeloma/attachment/johnson-2/ 2020-07-27T10:44:33+00:00 https://www.pharmaceutical-business-review.com/news/celltrion-secures-ec-approval-for-remsima-sc-for-five-more-indications/attachment/1131px-european_commission_in_brussels-1/ 2020-07-28T10:58:14+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-bnt162b2-vaccine/attachment/biontech-2/ 2020-07-28T10:58:55+00:00 https://www.pharmaceutical-business-review.com/news/neoimmunetech-gets-ind-clearance-for-nt-i7-trial-in-locally-recurrent-scchn/attachment/cancer-cells-541954_640-7/ 2020-07-28T11:07:29+00:00 https://www.pharmaceutical-business-review.com/news/ai-therapeutics-announces-start-of-phase-ii-trial-of-lam-002a-to-treat-covid-19-patients/attachment/ai/ 2020-07-28T11:33:42+00:00 https://www.pharmaceutical-business-review.com/contractors/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/news/lts-livzon-license/attachment/ltslohmann-livzon-1-1200x675/ 2020-07-28T14:51:36+00:00 https://www.pharmaceutical-business-review.com/news/dfc-kodak-pharma-business/attachment/kodak_tower/ 2020-07-29T01:55:45+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-ckd-trial/attachment/astrazeneca-headquarters-3/ 2020-07-29T06:13:57+00:00 https://www.pharmaceutical-business-review.com/news/karuna-therapeutics-and-psychogenics-announce-drug-discovery-collaboration/attachment/handshake-3298455_640-42/ 2020-07-29T06:19:46+00:00 https://www.pharmaceutical-business-review.com/contractors/vetter_pharma_international/news/carbon-dioxide-neutral/attachment/200227_vetterlogo_co2neutral-fin-v3/ 2020-07-29T14:59:42+00:00 https://www.pharmaceutical-business-review.com/news/nura-bio-launches-to-discover-and-develop-neuroprotective-drug/attachment/neuro-bio/ 2020-07-30T10:32:29+00:00 https://www.pharmaceutical-business-review.com/news/roches-tocilizumab-covid-19/attachment/covidroche/ 2020-07-30T10:43:08+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pevonedistat-hr-mds/attachment/takeda-10/ 2020-07-31T08:56:31+00:00 https://www.pharmaceutical-business-review.com/news/sab-biotherapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-of-sab-176-for-seasonal-influenza/attachment/sab-2/ 2020-07-31T11:07:44+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-covid-19-vaccine-study/attachment/pfizerworldheadquartersentrance-15/ 2020-08-03T03:07:32+00:00 https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-paediatric-psoriasis/attachment/novartis-6/ 2020-08-03T10:04:04+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-roches-tecentriq-plus-cotellic-and-zelboraf-for-people-with-advanced-melanoma/attachment/fda-drug-22/ 2020-08-03T11:19:10+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-gsk-to-supply-us-govt-with-100-million-doses-of-covid-19-vaccine/attachment/coronavirus-5394069_640/ 2020-08-03T11:19:16+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-epilepsy-drug-depakine/attachment/epilepsy/ 2020-08-04T09:29:36+00:00 https://www.pharmaceutical-business-review.com/news/abcellera-provides-covid-19-programme-update-with-start-of-phase-3-clinical-trials/attachment/coronatrial/ 2020-08-04T11:13:07+00:00 https://www.pharmaceutical-business-review.com/news/immunitybio-had5-vaccine-covid-19/attachment/coronavirus-disease-covid-2019-5060427_640/ 2020-08-04T11:18:46+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-ind-for-pscs-stem-cell-therapy-candidate-for-covid-19/attachment/dna-5297378_640-2/ 2020-08-04T11:26:52+00:00 https://www.pharmaceutical-business-review.com/news/reviral-sisunatovir-rsv-infection/attachment/fda-drug-23/ 2020-08-05T08:31:43+00:00 https://www.pharmaceutical-business-review.com/suppliers/experic/attachment/experic-equipment/ 2020-08-05T09:59:46+00:00 https://www.pharmaceutical-business-review.com/suppliers/experic/attachment/experic-hq/ 2020-08-05T09:59:51+00:00 https://www.pharmaceutical-business-review.com/suppliers/experic/attachment/experic-lab/ 2020-08-05T09:59:57+00:00 https://www.pharmaceutical-business-review.com/suppliers/experic/attachment/experic-lab2/ 2020-08-05T10:00:02+00:00 https://www.pharmaceutical-business-review.com/suppliers/experic/attachment/experic_logo/ 2020-08-05T10:00:15+00:00 https://www.pharmaceutical-business-review.com/news/myr-pharmaceuticals-receives-conditional-marketing-authorisation-by-european-commission-for-hepcludex/attachment/euro/ 2020-08-05T10:40:30+00:00 https://www.pharmaceutical-business-review.com/news/rlf-100-phase-2-3-clinical-trial/attachment/corona-5401250_640-1/ 2020-08-05T11:40:05+00:00 https://www.pharmaceutical-business-review.com/news/seismic-bio-partners-with-twist-bioscience-for-discovery-and-optimisation-of-antibodies/attachment/deal-4131445_640-12/ 2020-08-05T11:44:08+00:00 https://www.pharmaceutical-business-review.com/news/gsk-blenrep-multiple-myeloma/attachment/gsk-house-7/ 2020-08-06T08:45:16+00:00 https://www.pharmaceutical-business-review.com/news/lorbrena-significantly-improves-progression-free-survival-in-first-line-alk-positive-lung-cancer/attachment/pfizer-21/ 2020-08-06T10:49:21+00:00 https://www.pharmaceutical-business-review.com/suppliers/novo-nordisk-pharmatech/attachment/nn-logo/ 2020-08-06T14:34:22+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-dovato-2/attachment/dovato/ 2020-08-07T08:34:40+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-astrazeneca-collaborate-to-evaluate-patritumab-deruxtecan-in-combination-with-tagrisso-in-egfr-mutated-nsclc/attachment/pharmatablet/ 2020-08-07T11:01:39+00:00 https://www.pharmaceutical-business-review.com/news/roche-spinal-muscular-atrophy/attachment/roche-office/ 2020-08-10T08:54:51+00:00 https://www.pharmaceutical-business-review.com/news/novavax-takeda-nvx%e2%80%91cov2373/attachment/1200px-takeda_pharmaceutical_company_tokyo_head_office_1/ 2020-08-10T10:33:07+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-announces-agreement-with-gilead-to-manufacture-remdesivir-to-treat-covid-19/attachment/gilead-7/ 2020-08-10T10:45:51+00:00 https://www.pharmaceutical-business-review.com/news/ligand-pharmaceuticals-pfenex/attachment/ligand-3/ 2020-08-11T08:45:33+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-veklury-nda/attachment/virus-4937553_640-2/ 2020-08-11T10:12:11+00:00 https://www.pharmaceutical-business-review.com/news/omeros-reports-positive-results-for-narsoplimab-in-treatment-of-covid-19-associated-ards/attachment/corona-5174671_640-3/ 2020-08-11T10:19:44+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-appili-therapeutics-to-expand-its-trial-of-favipiravir-for-prrevention-of-covid-19/attachment/flavir/ 2020-08-11T11:15:36+00:00 https://www.pharmaceutical-business-review.com/news/bayer-kandy-therapeutics/attachment/bayer-3/ 2020-08-12T11:13:50+00:00 https://www.pharmaceutical-business-review.com/news/moderna-announces-supply-agreement-with-us-government-for-initial-100-million-doses-of-mrna-vaccine-against-covid-19/attachment/coronadose/ 2020-08-12T11:55:12+00:00 https://www.pharmaceutical-business-review.com/news/sab-biotherapeutics-sab-185-phase-1-trial/attachment/coronavirus-4972480_640-13/ 2020-08-12T15:11:33+00:00 https://www.pharmaceutical-business-review.com/news/genecentric-janssen-nmibc/attachment/pharmatablet-2/ 2020-08-13T11:00:56+00:00 https://www.pharmaceutical-business-review.com/news/inpedild-trial-enrols-first-patient-to-evaluate-nintedanib-in-pediatric-population-with-fibrosing-ild/attachment/1200px-siedziba_boehringer_ingelheim_w_polsce/ 2020-08-13T11:08:01+00:00 https://www.pharmaceutical-business-review.com/news/blade-therapeutics-updates-enrolment-progress-for-covid-19-pneumonia-study-of-bld-2660/attachment/blade/ 2020-08-13T11:14:18+00:00 https://www.pharmaceutical-business-review.com/news/enzychem-covid-19-pneumonia/attachment/enzymate/ 2020-08-14T08:57:21+00:00 https://www.pharmaceutical-business-review.com/news/union-therapeutics-to-acquire-licence-for-covid-19-technologies-developed-by-tff-pharmaceuticals/attachment/union/ 2020-08-14T11:55:15+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-principia-biopharma/attachment/sanofi-4/ 2020-08-17T09:10:46+00:00 https://www.pharmaceutical-business-review.com/uncategorized/chugais-enspryng-receives-regulatory-approval-from-fda-for-neuromyelitis-optica-spectrum-disorder/attachment/fda-drug-24/ 2020-08-17T10:13:10+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-azd1222-vaccine-ec-deal/attachment/astrazeneca-headquarters-4/ 2020-08-17T10:47:52+00:00 https://www.pharmaceutical-business-review.com/news/first-hbv-patient-dosed-in-phase-iia-clinical-trial-of-asc22/attachment/test-214185_640-11/ 2020-08-17T10:53:57+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/nsf-health-sciences-journal-new/attachment/112957048_xl-2/ 2020-08-17T13:26:20+00:00 https://www.pharmaceutical-business-review.com/news/bms-dragonfly-therapeutics-il-12/attachment/bristol-myers-squibb/ 2020-08-18T06:41:42+00:00 https://www.pharmaceutical-business-review.com/news/bold-100-significantly-outperforms-remdesivir-head-to-head-in-sars-cov-2-model/attachment/doctor-patient/ 2020-08-18T10:57:47+00:00 https://www.pharmaceutical-business-review.com/news/gni-group-announces-positive-results-from-study-of-f351-as-therapy-for-hbv-related-liver-fibrosis-in-china/attachment/liver-7/ 2020-08-18T10:59:36+00:00 https://www.pharmaceutical-business-review.com/news/gilead-tango-immuno-oncology/attachment/gilead-8/ 2020-08-18T12:38:58+00:00 https://www.pharmaceutical-business-review.com/news/agilent-frederick-facility/attachment/nucleic-acid/ 2020-08-19T07:49:28+00:00 https://www.pharmaceutical-business-review.com/news/lilly-innovent-tyvyt-licensing-deal/attachment/lilly-corporate-center-2/ 2020-08-19T10:26:06+00:00 https://www.pharmaceutical-business-review.com/news/europes-largest-initiative-launches-to-accelerate-therapy-development-for-covid-19/attachment/europe/ 2020-08-19T16:39:29+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-momenta-pharmaceuticals/attachment/johnson-johnson-headquarters/ 2020-08-20T08:14:08+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-achieves-enrolment-target-in-phase-3-genesis-trial-for-planned-interim-analysis/attachment/science-1336663_640-4/ 2020-08-20T11:05:23+00:00 https://www.pharmaceutical-business-review.com/news/novartis-kesimpta-multiple-sclerosis/attachment/novartis-7/ 2020-08-21T08:37:35+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-share-positive-early-data-on-mrna-vaccine-candidate-bnt162b2-against-covid-19/attachment/covid-3/ 2020-08-21T10:01:05+00:00 https://www.pharmaceutical-business-review.com/news/abcellera-acquires-orthomab-bispecific-platform-from-dualogics/attachment/business-4109459_640-2/ 2020-08-21T10:53:22+00:00 https://www.pharmaceutical-business-review.com/news/blackstone-takeda-consumer/attachment/takeda-11/ 2020-08-24T08:34:04+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-eua-for-convalescent-plasma-as-potential-promising-covid-19-treatment/attachment/fda-drug-25/ 2020-08-24T10:27:32+00:00 https://www.pharmaceutical-business-review.com/news/sab-biotherapeutics-sab-185-phase-1-trial/attachment/covid-19-4907621_640-1/ 2020-08-24T10:36:30+00:00 https://www.pharmaceutical-business-review.com/news/sab-185-phase-1b-trial-covid-19/attachment/coronavirus-4972480_640-14/ 2020-08-24T10:39:31+00:00 https://www.pharmaceutical-business-review.com/news/novartis-phase-3-combi-i-trial-fails-to-meet-primary-endpoint/attachment/tower-with-logo-through-branches-image-2/ 2020-08-24T10:54:01+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-forbius/attachment/bristol-myers-squibb-2/ 2020-08-25T08:54:48+00:00 https://www.pharmaceutical-business-review.com/news/catalent-azd1222-manufacturing-us/attachment/syringe-417786_640-2/ 2020-08-25T11:09:47+00:00 https://www.pharmaceutical-business-review.com/news/odonate-announces-positive-top-line-results-for-tesetaxel-in-phase-3-metastatic-breast-cancer-trial/attachment/science-1336663_640-5/ 2020-08-25T11:18:52+00:00 https://www.pharmaceutical-business-review.com/news/acadia-cersci-therapeutics/attachment/acadia/ 2020-08-26T08:07:30+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-signs-agreement-with-bio-farma-indonesia-for-covi-19-vaccine-cooperation/attachment/sino/ 2020-08-26T09:44:56+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-azd7442-phase-1-trial/attachment/astrazeneca-headquarters-5/ 2020-08-26T10:31:53+00:00 https://www.pharmaceutical-business-review.com/news/gsk-blenrep-multiple-myeloma-2/attachment/gsk-house-8/ 2020-08-27T07:59:53+00:00 https://www.pharmaceutical-business-review.com/news/hifibio-submits-ind-application-for-sars-cov-2-neutralising-antibody-to-treat-covid-19-patients/attachment/hibibo/ 2020-08-27T09:30:05+00:00 https://www.pharmaceutical-business-review.com/news/novartis-abl001-meets-primary-endpoint-of-phase-3-chronic-myeloid-leukemia-study/attachment/novartis-building-pnd/ 2020-08-27T10:57:29+00:00 https://www.pharmaceutical-business-review.com/news/beigene-singlomics-covid-19/attachment/begine/ 2020-08-28T08:15:41+00:00 https://www.pharmaceutical-business-review.com/news/treadwell-initiates-expansion-of-cohorts-in-phase-1-study-of-cfi-402257/attachment/lab-3498584_640-3/ 2020-08-28T10:42:55+00:00 https://www.pharmaceutical-business-review.com/news/rocket-pharmaceuticals-receives-fda-fast-track-designation-for-rp-l401-gene-therapy-for-infantile-malignant-osteopetrosis/attachment/fda-drug-27/ 2020-08-28T10:45:40+00:00 https://www.pharmaceutical-business-review.com/news/gilead-veklury-covid-19/attachment/gilead-9/ 2020-08-31T08:25:09+00:00 https://www.pharmaceutical-business-review.com/news/fsd-pharma-fsd201-phase-2-trial-fda/attachment/corona-5174671_640-4/ 2020-08-31T10:47:40+00:00 https://www.pharmaceutical-business-review.com/news/celltrion-receives-korean-mfds-approval-to-initiate-trial-of-covid-19-antiviral-antibody-treatment-candidate/attachment/korea/ 2020-08-31T11:07:28+00:00 https://www.pharmaceutical-business-review.com/news/ionis-akcea-therapeutics/attachment/ionis/ 2020-09-01T08:27:08+00:00 https://www.pharmaceutical-business-review.com/news/orpheris-enrols-first-patients-in-phase-2-clinical-study-evaluating-op-101-for-severe-covid-19/attachment/orpheris/ 2020-09-01T10:05:09+00:00 https://www.pharmaceutical-business-review.com/news/vir-gsk-vir-7831-phase-2-3-trial/attachment/injecting-519389_640/ 2020-09-01T10:28:20+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-announces-submission-of-snda-to-fda-for-cabometyx-plus-opdivo-for-advanced-rcc/attachment/fda-drug-26/ 2020-09-01T10:36:25+00:00 https://www.pharmaceutical-business-review.com/contractors/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/news/microarray-patch-systems-webinar/attachment/map-webinar-bild/ 2020-09-01T13:49:23+00:00 https://www.pharmaceutical-business-review.com/news/clear-creek-bio-brequinar/attachment/cleat-creek/ 2020-09-02T08:23:04+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-onureg-as-continued-treatment-for-adults-in-first-remission-with-aml/attachment/fda-drug-28/ 2020-09-02T10:05:53+00:00 https://www.pharmaceutical-business-review.com/news/gilead-jounce-therapeutics-licensing-deal/attachment/cancer-cells-541954_640-8/ 2020-09-02T10:25:48+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-gsk-covid-19-vaccine/attachment/gscorona/ 2020-09-03T08:53:40+00:00 https://www.pharmaceutical-business-review.com/news/twist-bioscience-announces-potent-sars-cov-2-neutralising-data-from-covid-19-therapeutic-antibody-programme/attachment/twist-2/ 2020-09-03T10:43:12+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyte-biotech-submits-ind-to-fda-for-clinical-trial-in-inoperable-pancreatic-cancer/attachment/science-1336663_640-6/ 2020-09-03T10:54:09+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-trulicity/attachment/elil-liil/ 2020-09-04T08:55:57+00:00 https://www.pharmaceutical-business-review.com/news/kite-hifibio-therapeutics-partner-to-discover-novel-targets-and-antibodies-against-aml/attachment/aml/ 2020-09-04T10:29:41+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-launches-phase-3-superiority-study-for-pans/attachment/lab-3498584_640-4/ 2020-09-04T10:58:30+00:00 https://www.pharmaceutical-business-review.com/news/roche-gavreto-nsclc/attachment/roche-office-2/ 2020-09-07T08:37:26+00:00 https://www.pharmaceutical-business-review.com/news/ampio-announces-enrolment-completion-for-intravenous-covid-19-clinical-trial/attachment/avacto/ 2020-09-07T09:59:34+00:00 https://www.pharmaceutical-business-review.com/news/grifols-alkahest-full-ownership/attachment/job-4131482_640-30/ 2020-09-07T10:40:23+00:00 https://www.pharmaceutical-business-review.com/news/novartis-says-high-dose-enerzair-breezhaler-reduces-asthma-exacerbations-versus-medium-dose/attachment/novartis-building-pnd-2/ 2020-09-07T11:31:22+00:00 https://www.pharmaceutical-business-review.com/news/janssen-imbruvica-rituximab/attachment/ecbuild-2/ 2020-09-08T08:28:04+00:00 https://www.pharmaceutical-business-review.com/news/bayer-adempas-phase-4-trial/attachment/bayer-headquarters/ 2020-09-08T11:07:35+00:00 https://www.pharmaceutical-business-review.com/news/cycle-pharmaceuticals-secures-25m-debt-financing/attachment/office-1209640_640-25/ 2020-09-08T11:12:21+00:00 https://www.pharmaceutical-business-review.com/news/mylan-aspen-thrombosis/attachment/aspen/ 2020-09-09T08:19:31+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-nbe-join-forces-for-discovery-and-development-of-adcs-for-cancer/attachment/cancer-cells-541954_640-9/ 2020-09-09T11:08:48+00:00 https://www.pharmaceutical-business-review.com/news/takeda-divests-select-non-core-assets-in-europe-to-cheplapharm-for-approximately-562m/attachment/takeda-12/ 2020-09-09T11:25:42+00:00 https://www.pharmaceutical-business-review.com/news/france-eye-drug-practices-novartis-roche/attachment/eye-2/ 2020-09-10T10:04:19+00:00 https://www.pharmaceutical-business-review.com/news/ascentage-pharmas-bcl-2-inhibitor-apg-2575-granted-orphan-drug-designation-by-fda-to-treat-chronic-lymphocytic-leukaemia/attachment/fda-drug-29/ 2020-09-10T10:48:57+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-to-supply-eu-with-200-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2/attachment/pfize/ 2020-09-10T10:49:48+00:00 https://www.pharmaceutical-business-review.com/news/axons-covid-19-vaccine/attachment/axon/ 2020-09-11T09:02:48+00:00 https://www.pharmaceutical-business-review.com/news/axons-covid-19-vaccine/attachment/axon-neuroscience-lab-technician/ 2020-09-11T09:51:51+00:00 https://www.pharmaceutical-business-review.com/news/terns-pharmaceuticals-receives-fast-track-designation-for-tern-201-as-a-treatment-for-nash/attachment/fda-drug-30/ 2020-09-11T11:19:53+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-dupixent/attachment/fda-drug-31/ 2020-09-14T08:32:09+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-acquire-immunomedics/attachment/job-4131482_640-31/ 2020-09-14T10:21:54+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-and-biontech-propose-expansion-of-pivotal-covid-19-vaccine-trial/attachment/covid-19-3/ 2020-09-14T11:31:18+00:00 https://www.pharmaceutical-business-review.com/suppliers/experic/whitepapers/mitigate-risk/attachment/experic_brochure_digital-pages_2-12-20_vf/ 2020-09-14T13:43:00+00:00 https://www.pharmaceutical-business-review.com/suppliers/experic/whitepapers/mitigate-risk/attachment/experic_casestudy_whitepaper_filling_js_7-30-20_vf/ 2020-09-14T13:43:03+00:00 https://www.pharmaceutical-business-review.com/news/merck-seattle-genetics/attachment/merck-2/ 2020-09-15T08:07:49+00:00 https://www.pharmaceutical-business-review.com/news/baricitinib-plus-remdesivir-reduces-time-to-recovery-in-covid-19-patients-in-niaid-sponsored-actt-2-trial/attachment/cor-virus/ 2020-09-15T10:22:45+00:00 https://www.pharmaceutical-business-review.com/news/hifibio-abl-bio-hfb30132a-covid-19/attachment/covid-19-4982910_640-11/ 2020-09-15T10:46:11+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-initiates-phase-2-study-of-patritumab-deruxtecan-in-advanced-colorectal-cancer/attachment/test-214185_640-12/ 2020-09-15T10:52:40+00:00 https://www.pharmaceutical-business-review.com/news/takeda-cell-therapy/attachment/tak/ 2020-09-16T08:30:07+00:00 https://www.pharmaceutical-business-review.com/news/melior-pharmaceuticals-awarded-grant-for-advancing-pulmonary-therapeutic-in-covid-19-phase-2-clinical-trial/attachment/meru/ 2020-09-16T09:03:33+00:00 https://www.pharmaceutical-business-review.com/news/gilead-magrolimab-mds-fda-breakthrough/attachment/cancer-cells-541954_640-11/ 2020-09-16T10:53:28+00:00 https://www.pharmaceutical-business-review.com/news/curasen-doses-first-subjects-in-phase-1-trial-of-cst-2032/attachment/blood-20745_640-2/ 2020-09-16T11:03:08+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-rdif-sputnik/attachment/sputnik/ 2020-09-17T08:45:44+00:00 https://www.pharmaceutical-business-review.com/news/moderna-chiesi-collaborate-to-develop-mrna-therapeutics-for-pulmonary-arterial-hypertension/attachment/drug-16/ 2020-09-17T10:53:47+00:00 https://www.pharmaceutical-business-review.com/products/clinical-supply-forecasting/attachment/supply-forecasting_57px/ 2020-09-17T14:05:20+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/750px_visual_black_for_d/ 2020-09-17T14:05:46+00:00 https://www.pharmaceutical-business-review.com/suppliers/s-clinica/attachment/750px_visual_black_for_d-3/ 2020-09-17T14:14:30+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-pcsk9-dogma-therapeutics/attachment/astrazeneca-headquarters-6/ 2020-09-18T05:34:21+00:00 https://www.pharmaceutical-business-review.com/news/santen-and-us-ophthalmic-company-eyevance-enter-into-share-purchase-agreement/attachment/hands-1445472_640-4/ 2020-09-18T05:42:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/global-central-laboratory/attachment/new-logo/ 2020-09-18T12:18:06+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/esource-arising/attachment/sgs-afl-esource-arising-tech-bulletin-en1/ 2020-09-21T07:48:57+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-gsk-covid-19/attachment/sanvaccine/ 2020-09-21T08:57:23+00:00 https://www.pharmaceutical-business-review.com/news/padcev-phase-3-trial-urothelial-cancer/attachment/padcev_20mg/ 2020-09-21T10:40:27+00:00 https://www.pharmaceutical-business-review.com/news/vifor-pharma-group-announces-successful-sale-of-om-pharma/attachment/om-pharma/ 2020-09-21T10:42:44+00:00 https://www.pharmaceutical-business-review.com/products/medchem-highlights/attachment/medchem-2/ 2020-09-21T10:44:28+00:00 https://www.pharmaceutical-business-review.com/products/coronavirus-library/attachment/covlib/ 2020-09-21T10:53:52+00:00 https://www.pharmaceutical-business-review.com/products/hit-locator-library/attachment/hll/ 2020-09-21T10:56:17+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/functionalized-vinyl-boronates/attachment/wp_02-11-20/ 2020-09-21T10:58:31+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/functionalized-vinyl-boronates/attachment/wp_05-10-20/ 2020-09-21T10:58:34+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/functionalized-vinyl-boronates/attachment/wp_16-11-20/ 2020-09-21T10:58:37+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/functionalized-vinyl-boronates/attachment/wp_19-10-20/ 2020-09-21T10:58:42+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/functionalized-vinyl-boronates/attachment/wp_21-09-20/ 2020-09-21T10:58:49+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/functionalized-vinyl-boronates/attachment/wp_30-11-20/ 2020-09-21T10:58:52+00:00 https://www.pharmaceutical-business-review.com/events/nitrosamine-impurities-whats-the-impact-on-imps/attachment/nitrosamine-impurities-what%ce%b3cos-the-impact-on-imps-linkedin-post_linkedin-2/ 2020-09-21T12:02:18+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/webinar-nitrosamine-impurities/attachment/nitrosamine-impurities-what%ce%b3cos-the-impact-on-imps-linkedin-post_linkedin/ 2020-09-21T12:02:32+00:00 https://www.pharmaceutical-business-review.com/news/roche-inflazome/attachment/roche-10/ 2020-09-22T07:57:14+00:00 https://www.pharmaceutical-business-review.com/news/bms-opdivo-checkmate-649-trial/attachment/bristol-myers-squibb-3/ 2020-09-22T10:19:21+00:00 https://www.pharmaceutical-business-review.com/news/onkure-pfizer-collaborate-to-evaluate-combination-of-oki-179-and-binimetinib/attachment/pfize-2/ 2020-09-22T10:20:23+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-covid-19-turkey/attachment/sinovac/ 2020-09-23T07:55:16+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-gsk-sign-agreements-with-government-of-canada-to-supply-72-million-doses-of-adjuvanted-covid-19-vaccine/attachment/gsk-9/ 2020-09-23T10:13:14+00:00 https://www.pharmaceutical-business-review.com/news/bms-bluebird-fda-priority-review-ide-cel/attachment/dna-5297378_640-3/ 2020-09-23T10:45:42+00:00 https://www.pharmaceutical-business-review.com/news/micreos-initiates-clinical-trial-to-evaluate-endolysin-drug-in-atopic-dermatitis/attachment/endolysin/ 2020-09-23T10:51:34+00:00 https://www.pharmaceutical-business-review.com/news/phase-3-trial-jnj-78436735-covid-19/attachment/johnson-johnson-headquarters-2/ 2020-09-24T06:08:44+00:00 https://www.pharmaceutical-business-review.com/news/permira-funds-to-acquire-european-cns-specialty-pharmaceutical-company-neuraxpharm/attachment/news_crop_neuraxpharm-building/ 2020-09-24T06:15:17+00:00 https://www.pharmaceutical-business-review.com/contractors/gerresheimer/news/respimat-inhaler/attachment/respimat/ 2020-09-24T09:37:20+00:00 https://www.pharmaceutical-business-review.com/news/oncoimmune-saccovid-covid-19/attachment/oncoimmune/ 2020-09-25T08:40:57+00:00 https://www.pharmaceutical-business-review.com/news/anokion-announces-fda-clearance-of-ind-application-for-ank-700-to-treat-multiple-sclerosis/attachment/fda-drug-32/ 2020-09-25T10:52:42+00:00 https://www.pharmaceutical-business-review.com/news/millendo-therapeutics-initiates-first-in-human-clinical-trial-of-mle-301/attachment/test-214185_640-13/ 2020-09-25T11:01:25+00:00 https://www.pharmaceutical-business-review.com/news/gsk-nucala-hypereosinophilic/attachment/gsk-house-9/ 2020-09-28T07:54:54+00:00 https://www.pharmaceutical-business-review.com/news/arena-doses-first-subject-in-elevate-uc-12-phase-3-trial-of-etrasimod-in-ulcerative-colitis/attachment/lab-3498584_640-5/ 2020-09-28T10:49:11+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/self-assessment-nitrosamine/attachment/4534-nsf-ps-nitrosamine-self-assessment-a4-mar-2021-closing-v1/ 2020-09-28T11:06:23+00:00 https://www.pharmaceutical-business-review.com/news/jj-gram-covid-19/attachment/john-2/ 2020-09-28T11:10:47+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-marketing-authorisation-for-jyseleca-to-treat-adults-with-moderate-to-severe-active-rheumatoid-arthritis/attachment/ec/ 2020-09-28T11:22:13+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-gets-fda-nod-for-xeljanz-to-treat-juvenile-idiopathic-arthritis/attachment/pfizer-22/ 2020-09-29T07:54:48+00:00 https://www.pharmaceutical-business-review.com/news/inovio-covid-19-vaccine/attachment/inovia/ 2020-09-29T10:14:25+00:00 https://www.pharmaceutical-business-review.com/news/avrobio-receives-orphan-drug-designation-from-european-medicines-agency-for-avr-rd-02/attachment/euro-2/ 2020-09-29T10:23:27+00:00 https://www.pharmaceutical-business-review.com/news/viiv-begins-implementation-science-study-for-hiv-treatment-regimen-candidate-in-europe/attachment/syringe-4544448_640/ 2020-09-29T10:30:59+00:00 https://www.pharmaceutical-business-review.com/news/medincell-covid-19-ivermectin/attachment/pix/ 2020-09-30T08:19:54+00:00 https://www.pharmaceutical-business-review.com/contractors/tosoh-bioscience/news/virtual-bioseparation-forum/attachment/logo-bioforum-in-one-linev4_hr/ 2020-09-30T10:41:20+00:00 https://www.pharmaceutical-business-review.com/news/kuur-therapeutics-announces-first-patients-dosed-with-allogeneic-car-nkt-cell-therapy/attachment/test-214185_640-14/ 2020-09-30T11:42:30+00:00 https://www.pharmaceutical-business-review.com/news/infinity-receives-fast-track-designation-for-eganelisib-in-combination-with-checkpoint-inhibitor-and-chemotherapy-for-advanced-tnbc/attachment/fda-drug-33/ 2020-09-30T11:44:19+00:00 https://www.pharmaceutical-business-review.com/news/orgenesis-koligo-therapeutics/attachment/adam/ 2020-09-30T12:02:00+00:00 https://www.pharmaceutical-business-review.com/news/baylx-receives-us-fda-clearance-of-covid-19-ind-application-for-umbilical-cord-tissue-mesenchymal-stem-cells-product/attachment/fda-drug-34/ 2020-10-01T10:36:13+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-reports-positive-results-from-illuminate-b-phase-3-study-of-lumasiran/attachment/science-1336663_640-7/ 2020-10-01T11:29:48+00:00 https://www.pharmaceutical-business-review.com/news/covis-group-amag-pharmaceuticals/attachment/amag-2/ 2020-10-01T17:54:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-fda-btd-ckd/attachment/astrazeneca-headquarters-7/ 2020-10-05T05:54:15+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-opdivo-to-treat-metastatic-sclc/attachment/bmsbuild/ 2020-10-05T11:27:09+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-myokardia/attachment/bms-facility-2/ 2020-10-06T08:50:18+00:00 https://www.pharmaceutical-business-review.com/news/immunogen-imgn632-bpdcn/attachment/fda-drug-35/ 2020-10-06T10:52:33+00:00 https://www.pharmaceutical-business-review.com/news/eureka-initiates-trial-to-evaluate-et140203-artemis-t-cell-therapy-in-hcc/attachment/cancer-cells-541954_640-12/ 2020-10-06T11:18:46+00:00 https://www.pharmaceutical-business-review.com/news/gsk-vir-biotechnology-covid-19/attachment/vir/ 2020-10-07T08:17:34+00:00 https://www.pharmaceutical-business-review.com/news/scribe-therapeutics-biogen-crispr/attachment/crisper/ 2020-10-07T11:10:26+00:00 https://www.pharmaceutical-business-review.com/news/biontech-pfizer-initiate-rolling-submission-to-ema-for-sars-cov-2-vaccine-candidate/attachment/biontech-3/ 2020-10-07T11:17:33+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-glycomimetics-rare-paediatric-disease-designation-for-rivipansel-for-treatment-of-sickle-cell-disease/attachment/fda-drug-36/ 2020-10-07T11:33:07+00:00 https://www.pharmaceutical-business-review.com/news/arca-fda-ind-approval-ab201/attachment/virus-4937553_640-3/ 2020-10-08T06:21:18+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-cstone-pharmaceuticals/attachment/pfizer-2-3/ 2020-10-08T11:14:42+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-covid-19/attachment/jandj-6/ 2020-10-09T07:36:57+00:00 https://www.pharmaceutical-business-review.com/news/noxopharm-announces-first-covid-19-patient-treated-in-veyonda-study/attachment/nexo/ 2020-10-09T11:11:08+00:00 https://www.pharmaceutical-business-review.com/news/ocular-therapeutix-announces-topline-phase-1-clinical-trial-results-of-otx-csi/attachment/oculo/ 2020-10-12T01:42:49+00:00 https://www.pharmaceutical-business-review.com/news/rigel-covid-19-trial-with-fostamatinib/attachment/rigel/ 2020-10-12T11:36:24+00:00 https://www.pharmaceutical-business-review.com/news/gannex-received-us-ind-approval-for-its-nash-drug-candidate-asc42/attachment/fda-drug-37/ 2020-10-12T11:53:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/streamlining-pharma-operations-covid-19/attachment/nsf-ph-white-paper-steamlining-pharma-operations-in-the-wake-of-covid-19/ 2020-10-12T14:26:51+00:00 https://www.pharmaceutical-business-review.com/news/jj-covid-19-vaccine/attachment/janj/ 2020-10-13T08:44:41+00:00 https://www.pharmaceutical-business-review.com/news/hitgen-to-acquire-fragment-and-structure-based-biotech-company-vernalis/attachment/structture/ 2020-10-13T09:35:08+00:00 https://www.pharmaceutical-business-review.com/news/seagen-astellas-report-positive-results-from-padcev-phase-2-trial-in-advanced-urothelial-cancer/attachment/test-214185_640-15/ 2020-10-13T10:59:46+00:00 https://www.pharmaceutical-business-review.com/news/world-bank-12bn-package-covid-19-vaccines/attachment/1112px-world_bank_building_at_washington-1/ 2020-10-14T07:13:46+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-inmazeb-fda-approval-ebola/attachment/regeneron-headquarters/ 2020-10-15T06:14:51+00:00 https://www.pharmaceutical-business-review.com/news/moderna-secures-eligibility-for-submission-of-maa-of-mrna-1273-to-ema/attachment/syringe-417786_640-3/ 2020-10-15T11:31:32+00:00 https://www.pharmaceutical-business-review.com/news/y-mabs-announces-fda-clearance-of-ind-for-its-lutetium-177-labelled-omburtamab-antibody/attachment/cancer-cells-541954_640-13/ 2020-10-15T11:38:04+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-disarm-therapeutics/attachment/lilly-3/ 2020-10-16T07:49:26+00:00 https://www.pharmaceutical-business-review.com/news/immunitybio-covid-19-vaccine/attachment/hd5/ 2020-10-16T10:17:07+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-expanded-indication-for-mercks-keytruda-in-adult-patients-with-relapsed-or-refractory-chl/attachment/fda-drug-38/ 2020-10-16T10:53:55+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-translate-bio-mrna-covid-19-vaccine-candidate-induced-high-antibody-levels-in-preclinical-studies/attachment/covid-19-4982910_640-13/ 2020-10-16T11:26:54+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-rdif-sputnik-v/attachment/sputnik-2/ 2020-10-19T09:09:08+00:00 https://www.pharmaceutical-business-review.com/news/genentech-announces-full-fda-approval-for-venclexta-combinations-for-acute-myeloid-leukemia/attachment/fda-drug-39/ 2020-10-19T11:15:38+00:00 https://www.pharmaceutical-business-review.com/news/dren-bio-announces-a-60m-series-a-financing/attachment/job-4131482_640-35/ 2020-10-19T11:59:20+00:00 https://www.pharmaceutical-business-review.com/news/vifor-pharma-cara-therapeutics/attachment/human-kidney/ 2020-10-20T08:31:13+00:00 https://www.pharmaceutical-business-review.com/news/versantis-receives-fda-rare-paediatric-disease-designation-for-vs-01-to-treat-urea-cycle-disorders/attachment/fda-drug-40/ 2020-10-20T11:09:54+00:00 https://www.pharmaceutical-business-review.com/news/velosbio-announces-first-patient-dosed-in-phase-2-trial-of-vls-101-in-solid-tumours/attachment/test-214185_640-16/ 2020-10-20T11:48:11+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-primary-mitochondrial/attachment/fda-drug-41/ 2020-10-21T07:59:11+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/managing-human-challenge-trials/attachment/sgs-afl-managing-human-challenge-trials-a-case-study-hr-20-08/ 2020-10-21T08:09:39+00:00 https://www.pharmaceutical-business-review.com/news/jsr-life-sciences-biologics/attachment/drug-substance/ 2020-10-21T10:14:15+00:00 https://www.pharmaceutical-business-review.com/news/xeris-pharmaceuticals-granted-fast-track-designation-by-fda-for-novel-concentrated-diazepam-formulation-for-injection/attachment/fda-drug-42/ 2020-10-21T10:24:06+00:00 https://www.pharmaceutical-business-review.com/news/immunitybio-nantkwest-covid-19/attachment/cor-2/ 2020-10-22T09:47:06+00:00 https://www.pharmaceutical-business-review.com/news/novartis-gets-fda-orphan-drug-status-for-branaplam-to-treat-huntingtons-disease/attachment/novartis-8/ 2020-10-22T11:50:36+00:00 https://www.pharmaceutical-business-review.com/news/effrx-pharmaceuticals-signs-exclusive-license-agreement-with-diurnal-for-registration-and-commercialisation-of-alkindi/attachment/tablt/ 2020-10-22T12:02:26+00:00 https://www.pharmaceutical-business-review.com/news/gilead-announces-new-data-on-biktarvy-for-the-treatment-of-hiv-in-black-americans/attachment/science-1336663_640-8/ 2020-10-22T12:04:28+00:00 https://www.pharmaceutical-business-review.com/news/fda-gilead-veklury-covid-19-approval/attachment/1200px-fda_bldg_51_-_main_entrance_5161374834/ 2020-10-23T05:44:46+00:00 https://www.pharmaceutical-business-review.com/suppliers/schott-pharma/whitepapers/delamination-glass-containers/attachment/763dcb34-c0a4-4383-9341-c9d19a3bf52d/ 2020-10-23T09:48:35+00:00 https://www.pharmaceutical-business-review.com/news/sirnaomics-seals-105m-series-d-financing-for-rnai-therapeutics/attachment/paper-3213924_640-4/ 2020-10-23T11:29:09+00:00 https://www.pharmaceutical-business-review.com/news/novartis-iptacopan-ema-orphan-drug-designation-igan/attachment/novartis-building-pnd-3/ 2020-10-26T07:02:56+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/streamlining-pharma-operations/attachment/nsf-ph-white-paper-steamlining-pharma-operations-in-the-wake-of-covid-19-2/ 2020-10-26T13:03:52+00:00 https://www.pharmaceutical-business-review.com/news/bayer-asklepios-biopharmaceutical/attachment/askbio-bioreactor/ 2020-10-27T07:56:13+00:00 https://www.pharmaceutical-business-review.com/news/ana-therapeutics-oral-niclosamide/attachment/trial-8/ 2020-10-27T10:44:11+00:00 https://www.pharmaceutical-business-review.com/news/moderna-to-supply-qatar-with-mrna-vaccine-against-covid-19/attachment/qatar/ 2020-10-27T10:50:50+00:00 https://www.pharmaceutical-business-review.com/news/hifibio-completes-first-cohort-of-phase-1-study-of-sars-cov-2-neutralising-antibody/attachment/coronavirus-4972480_640-15/ 2020-10-27T11:41:03+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-voclosporin-covid-19/attachment/volarin/ 2020-10-28T07:29:48+00:00 https://www.pharmaceutical-business-review.com/news/gsk-sanofi-covid-19-2/attachment/covax/ 2020-10-28T10:48:23+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-ibrance-breast-cancer/attachment/pfizer-23/ 2020-10-28T11:48:56+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-antibody-bamlanivimab/attachment/lilly-4/ 2020-10-29T07:47:33+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/detection-of-ultra-small-residual-masses/attachment/detection-of-ultra-small-residual-masses-weigh-the-little-bird/ 2020-10-29T09:32:50+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/detection-of-ultra-small-residual-masses/attachment/efficient-substance-identification-using-identify/ 2020-10-29T09:32:54+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/detection-of-ultra-small-residual-masses/attachment/investigating-the-purity-of-substances-by-means-of-dsc/ 2020-10-29T09:32:58+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/detection-of-ultra-small-residual-masses/attachment/lifetime-predictions-based-on-climate-temperature-profiles/ 2020-10-29T09:33:03+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/detection-of-ultra-small-residual-masses/attachment/monitoring-the-polymorphism-of-paracetamol-by-means-of-dsc/ 2020-10-29T09:33:08+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/purity-determination/attachment/the-importance-of-purity-determination-of-pharmaceuticals/ 2020-10-29T09:50:17+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/lyophilisation-processes/attachment/the-role-of-dsc-in-lyophilisation-processes/ 2020-10-29T09:51:45+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-insitro/attachment/bms-5/ 2020-10-29T10:36:09+00:00 https://www.pharmaceutical-business-review.com/news/novartis-collaborates-with-molecular-partners-to-develop-two-darpin-therapies-designed-for-covid-19/attachment/novar-9/ 2020-10-29T10:43:39+00:00 https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-announces-fda-approval-of-eysuvis-for-short-term-treatment-of-dry-eye-disease/attachment/fda-drug-43/ 2020-10-29T11:48:56+00:00 https://www.pharmaceutical-business-review.com/news/novartis-vedere-bio/attachment/novartis-9/ 2020-10-30T07:59:21+00:00 https://www.pharmaceutical-business-review.com/news/humanigen-announces-first-patient-dosed-in-nih-activ-5-big-effect-trial-evaluating-lenzilumab-for-covid-19/attachment/big-effect/ 2020-10-30T10:22:19+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-zejula-as-first-line-monotherapy-maintenance-treatment-in-advanced-ovarian-cancer/attachment/701px-glaxosmithkline_building_london_30_july_2007_cropped/ 2020-10-30T11:15:41+00:00 https://www.pharmaceutical-business-review.com/news/cheplapharm-astrazeneca/attachment/astradeal/ 2020-11-02T07:58:04+00:00 https://www.pharmaceutical-business-review.com/suppliers/novo-nordisk-pharmatech/whitepapers/safeguarding-your-regulatory-compliance/attachment/regulatory-compliance/ 2020-11-02T09:34:14+00:00 https://www.pharmaceutical-business-review.com/news/novartis-adakveo-pain-crises/attachment/novarbuilding-4/ 2020-11-02T10:26:21+00:00 https://www.pharmaceutical-business-review.com/news/humanigen-announces-first-patient-dosed-in-phase-3-clinical-study-of-lenzilumab-in-covid-19/attachment/upjon/ 2020-11-02T10:35:21+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-horizon-discovery/attachment/horizon/ 2020-11-03T08:41:58+00:00 https://www.pharmaceutical-business-review.com/news/cepi-clover-covid-19/attachment/clover/ 2020-11-03T11:24:30+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-offers-to-acquire-clinical-stage-company-kiadis/attachment/san/ 2020-11-03T11:33:50+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbs-deucravacitinib/attachment/bmsfacility-6/ 2020-11-04T08:33:25+00:00 https://www.pharmaceutical-business-review.com/news/acg-india-iqgen-x/attachment/acg/ 2020-11-04T11:01:53+00:00 https://www.pharmaceutical-business-review.com/news/ionis-and-akcea-announce-that-pfizer-initiated-clinical-study-of-vupanorsen/attachment/pfizerworld-14/ 2020-11-04T11:11:21+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-initiates-phase-3-study-of-nabiximols-for-multiple-sclerosis-associated-spasticity/attachment/test-214185_640-17/ 2020-11-04T11:32:36+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-gets-eu-approval-for-heart-failure-drug-forxiga/attachment/heart-drug/ 2020-11-05T07:51:29+00:00 https://www.pharmaceutical-business-review.com/news/xnk-therapeutics-receives-us-orphan-drug-status-for-nk-cell-based-immunotherapy-in-multiple-myeloma/attachment/azureplat/ 2020-11-05T10:23:48+00:00 https://www.pharmaceutical-business-review.com/news/xnk-therapeutics-receives-us-orphan-drug-status-for-nk-cell-based-immunotherapy-in-multiple-myeloma/attachment/fda-drug-44/ 2020-11-05T10:24:11+00:00 https://www.pharmaceutical-business-review.com/news/nanology-enrols-first-patient-in-phase-2-trial-of-nanopac-for-intratumoral-treatment-of-prostate-cancer/attachment/science-1336663_640-9/ 2020-11-05T11:38:05+00:00 https://www.pharmaceutical-business-review.com/news/merck-velosbio/attachment/merck-3/ 2020-11-06T07:45:51+00:00 https://www.pharmaceutical-business-review.com/news/tff-pharmaceuticals-felix-biotechnology-sign-loi-for-collaboration-development-and-licence-agreement/attachment/drypowder/ 2020-11-06T09:57:01+00:00 https://www.pharmaceutical-business-review.com/news/novartis-canakinumab/attachment/novar-10/ 2020-11-09T08:35:58+00:00 https://www.pharmaceutical-business-review.com/news/pharmaron-acquires-absorption-systems-in-us/attachment/cro-2/ 2020-11-09T10:33:51+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19/attachment/pfizervaccine/ 2020-11-10T08:50:50+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-gets-fda-eua-status-for-bamlanivimab-to-treat-covid-19/attachment/eli-2/ 2020-11-10T11:51:08+00:00 https://www.pharmaceutical-business-review.com/news/sedor-pharmaceuticals-gets-fda-approval-for-sesquient-to-treat-status-epilepticus/attachment/fda-drug-45/ 2020-11-10T11:56:38+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-says-cabotegravir-is-superior-to-oral-standard-of-care-for-hiv-prevention-in-women/attachment/science-1336663_640-10/ 2020-11-10T12:13:44+00:00 https://www.pharmaceutical-business-review.com/news/medigen-bluewillow-sars-cov-2/attachment/blue-willow/ 2020-11-11T08:35:28+00:00 https://www.pharmaceutical-business-review.com/news/forma-therapeutics-sickle/attachment/europe-2/ 2020-11-11T11:19:57+00:00 https://www.pharmaceutical-business-review.com/news/immunitybio-nantkwest-announce-positive-interim-phase-1-safety-data-of-had5-covid-19-vaccine-dose-study/attachment/immune-bio/ 2020-11-11T11:29:33+00:00 https://www.pharmaceutical-business-review.com/news/russian-sputnik-v-vaccine/attachment/vaccine/ 2020-11-12T08:54:38+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-launches-phase-2-trial-to-evaluate-camostat-mesilate-for-covid-19-treatment/attachment/sagent/ 2020-11-12T10:31:55+00:00 https://www.pharmaceutical-business-review.com/suppliers/strategikon-pharma/attachment/cover/ 2020-11-12T13:16:37+00:00 https://www.pharmaceutical-business-review.com/suppliers/strategikon-pharma/attachment/lead-dashboard/ 2020-11-12T13:17:25+00:00 https://www.pharmaceutical-business-review.com/suppliers/strategikon-pharma/attachment/portfolio-comparison-covid/ 2020-11-12T13:17:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/strategikon-pharma/attachment/source-patients/ 2020-11-12T13:18:02+00:00 https://www.pharmaceutical-business-review.com/suppliers/strategikon-pharma/attachment/strategikon-logo/ 2020-11-12T13:25:20+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-calquence-covid-19/attachment/astra-9/ 2020-11-13T04:04:01+00:00 https://www.pharmaceutical-business-review.com/news/merck-keytruda-breast-cancer/attachment/fda-drug-46/ 2020-11-16T09:27:34+00:00 https://www.pharmaceutical-business-review.com/news/roche-lead-pharma/attachment/rochebasel-7/ 2020-11-16T11:52:14+00:00 https://www.pharmaceutical-business-review.com/news/vicore-pharma-recruits-the-first-patient-in-the-phase-2-proof-of-concept-study-in-idiopathic-pulmonary-fibrosis/attachment/test-214185_640-18/ 2020-11-16T12:11:30+00:00 https://www.pharmaceutical-business-review.com/news/moderna-covid-19/attachment/moderna-3/ 2020-11-17T08:06:53+00:00 https://www.pharmaceutical-business-review.com/news/inovio-covid-19-vaccine-2/attachment/ino/ 2020-11-17T11:22:28+00:00 https://www.pharmaceutical-business-review.com/news/merck-advances-phase-3-trial-for-islatravir-as-once-monthly-oral-prep-for-women-at-high-risk-for-acquiring-hiv-1/attachment/test-214185_640-19/ 2020-11-17T12:11:15+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-cabotegravir/attachment/hiv-treatment/ 2020-11-18T08:40:36+00:00 https://www.pharmaceutical-business-review.com/news/moderna-announces-supply-agreement-with-uk-government-to-supply-covid-19-mrna-vaccine/attachment/covidvaccine/ 2020-11-18T11:06:42+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbf-myokardia/attachment/bms-facility-3/ 2020-11-18T11:38:03+00:00 https://www.pharmaceutical-business-review.com/news/cerebral-therapeutics-announces-enrolment-of-first-patient-in-phase-2b-trial-in-epilepsy/attachment/laboratory-3827736_640-2/ 2020-11-18T12:16:23+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-primary-efficacy-endpoints/attachment/pfizer-24/ 2020-11-19T08:54:24+00:00 https://www.pharmaceutical-business-review.com/news/rilzabrutinib-granted-fda-fast-track-designation-for-treatment-of-immune-thrombocytopenia/attachment/pfizer-25/ 2020-11-19T10:58:04+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-expanded-access-ind-for-apts-phagebank-therapy-for-covid-19-related-bacterial-infections/attachment/apt_photo/ 2020-11-19T11:59:39+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-incyte/attachment/lilly-5/ 2020-11-20T08:34:59+00:00 https://www.pharmaceutical-business-review.com/news/novartis-secures-exclusive-rights-for-potential-acute-respiratory-distress-syndrome-cell-therapy/attachment/novar-11/ 2020-11-20T10:11:37+00:00 https://www.pharmaceutical-business-review.com/news/zymeworks-gets-ecs-orphan-drug-designation-for-zanidatamab-in-patients-with-gastric-cancer/attachment/mitosis-3876669_640-1/ 2020-11-20T11:38:10+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-seek-fda-eua-status-for-covid-19-vaccine/attachment/pfizer-26/ 2020-11-23T09:25:25+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-azd1222-vaccine/attachment/adeno/ 2020-11-23T11:34:15+00:00 https://www.pharmaceutical-business-review.com/news/amylyx-announces-fda-granted-orphan-drug-designation-for-amx0035-to-treat-wolfram-syndrome/attachment/fda-drug-48/ 2020-11-23T11:46:00+00:00 https://www.pharmaceutical-business-review.com/news/clear-creek-bio-doses-first-patient-in-phase-2-outpatient-study-of-brequinar-to-treat-covid-19/attachment/trial-9/ 2020-11-23T11:48:28+00:00 https://www.pharmaceutical-business-review.com/news/merck-oncoimmune/attachment/merck-4/ 2020-11-24T01:29:30+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-doses-first-participant-in-phase-3-study-evaluating-anti-tfpi-investigational-therapy/attachment/pfize-3/ 2020-11-24T11:23:50+00:00 https://www.pharmaceutical-business-review.com/news/hifibio-partners-with-pharmsynthez-and-ibch-to-develop-and-commercialise-sars-cov-2-neutralising-antibody-in-russia/attachment/covid-19-4982910_640-14/ 2020-11-24T11:55:04+00:00 https://www.pharmaceutical-business-review.com/news/gsk-rsv-maternal-candidat/attachment/gsk-house-10/ 2020-11-24T12:16:41+00:00 https://www.pharmaceutical-business-review.com/news/city-of-hope-covid-19/attachment/city-of-hope/ 2020-11-25T09:51:57+00:00 https://www.pharmaceutical-business-review.com/news/apnimed-doses-first-patient-in-phase-2-trial-of-ad109-in-obstructive-sleep-apnea/attachment/lab-3498584_640-6/ 2020-11-25T11:37:54+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-clears-appili-therapeutics-for-new-phase-3-trial-to-assess-avigan-to-prevent-covid-19/attachment/covidcanada/ 2020-11-25T11:44:47+00:00 https://www.pharmaceutical-business-review.com/news/roche-xofluza/attachment/basel-7/ 2020-11-25T12:07:11+00:00 https://www.pharmaceutical-business-review.com/news/moderna-covid-19-2/attachment/european-commission/ 2020-11-26T08:12:24+00:00 https://www.pharmaceutical-business-review.com/news/lupin-announces-fda-filing-acceptance-of-snda-for-solosec-to-treat-trichomoniasis/attachment/fda-drug-47/ 2020-11-26T11:21:54+00:00 https://www.pharmaceutical-business-review.com/news/celltrion-completes-enrolment-for-global-phase-ii-clinical-trial-with-covid-19-treatment-candidate/attachment/corcandidate/ 2020-11-26T11:23:40+00:00 https://www.pharmaceutical-business-review.com/news/astellas-anaemia-evrenzo/attachment/kidney-5/ 2020-11-27T08:48:23+00:00 https://www.pharmaceutical-business-review.com/news/haoma-medica-completes-first-in-human-trial-for-naquinate/attachment/osteo/ 2020-11-27T11:01:56+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-application-for-tepotinib-for-treatment-of-advanced-nsclc-with-metex14-skipping-alterations/attachment/mitosis-3876669_640-2/ 2020-11-27T11:10:38+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/cyclic-sulfates-sulfamidates/attachment/enamine_n-trifluoromethyl-azoles_2020-attachment-pdf/ 2020-11-27T16:59:12+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/cyclic-sulfates-sulfamidates/attachment/enamine_cyclic_sulfates_and_sulfamidates-attachment/ 2020-11-27T16:59:17+00:00 https://www.pharmaceutical-business-review.com/news/vertex-symkevi-kalydeco/attachment/euro-comm/ 2020-11-30T09:24:00+00:00 https://www.pharmaceutical-business-review.com/news/telix-pharmaceuticals-acquires-swiss-german-biotechnology-company-therapharm/attachment/thera/ 2020-11-30T11:20:33+00:00 https://www.pharmaceutical-business-review.com/news/biogen-drug-sage-therapeutics/attachment/depression-2/ 2020-11-30T12:22:56+00:00 https://www.pharmaceutical-business-review.com/news/moderna-covid-19-vaccine-2/attachment/moderna-4/ 2020-12-01T07:26:09+00:00 https://www.pharmaceutical-business-review.com/news/neoimmunetech-covid-19/attachment/immune-2/ 2020-12-01T09:49:15+00:00 https://www.pharmaceutical-business-review.com/news/zymeworks-gets-fda-breakthrough-therapy-status-for-her2-targeted-bispecific-antibody-zanidatamab-in-patients-with-btc/attachment/immune-3/ 2020-12-01T10:06:54+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sab-biotherapeutics-awarded-57-5m-from-barda-and-us-department-of-defense-for-sab-185/attachment/covid-19-4982910_640-15/ 2020-12-01T11:41:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-takeda-covid-19/attachment/take/ 2020-12-02T02:08:46+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-signs-agreement-to-divest-btg-specialty-pharmaceuticals-business/attachment/boston/ 2020-12-02T10:30:55+00:00 https://www.pharmaceutical-business-review.com/news/appili-announces-dosing-of-first-patient-in-phase-3-covid-19-trial/attachment/appili/ 2020-12-03T10:15:05+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-announces-650000-additional-doses-of-bamlanivimab-purchased-by-us-government-to-treat-covid-19/attachment/eli-lilly-7/ 2020-12-03T10:25:05+00:00 https://www.pharmaceutical-business-review.com/news/fda-roche-xofluza-flu/attachment/rochebuild-3/ 2020-12-03T11:29:58+00:00 https://www.pharmaceutical-business-review.com/news/janssen-hemera-eye/attachment/human/ 2020-12-04T08:33:32+00:00 https://www.pharmaceutical-business-review.com/news/neurogene-announces-ema-grants-orphan-drug-designation-for-aaspartylglucosaminuria-gene-therapy/attachment/fda-drug-49/ 2020-12-04T11:57:42+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-covid-19-vaccine/attachment/sinovac-2/ 2020-12-07T02:34:45+00:00 https://www.pharmaceutical-business-review.com/news/syros-acquires-clinical-stage-drug-candidate-for-acute-promyelocytic-leukemia/attachment/phar-2/ 2020-12-07T10:40:28+00:00 https://www.pharmaceutical-business-review.com/suppliers/strategikon-pharma/attachment/cover-2/ 2020-12-07T14:23:10+00:00 https://www.pharmaceutical-business-review.com/news/inovio-covid-19-vaccine-3/attachment/inovio/ 2020-12-08T04:36:02+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech/attachment/pfizer-27/ 2020-12-08T12:10:50+00:00 https://www.pharmaceutical-business-review.com/news/cybin-signs-agreement-to-acquire-adelia-therapeutics/attachment/cby/ 2020-12-08T12:12:26+00:00 https://www.pharmaceutical-business-review.com/news/amgen-sotorasib-nsclc/attachment/amgen-3/ 2020-12-09T01:47:34+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-azd1222-vaccine-efficacy/attachment/cq5dam-web-1200-cgi-aerial-view-2/ 2020-12-09T05:55:52+00:00 https://www.pharmaceutical-business-review.com/news/piramal-pharma-solutions-invests-32m-to-expand-riverview-michigan-facility/attachment/headache-1540220_640/ 2020-12-09T11:37:36+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-announces-325m-of-funding-from-royalty-pharma-and-athyrium-capital-management/attachment/conclusion-of-the-contract-3100563_640/ 2020-12-09T11:42:00+00:00 https://www.pharmaceutical-business-review.com/news/canada-approves-bnt162b2-covid-19/attachment/pfizerworldheadquartersentrance-16/ 2020-12-10T05:51:51+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-further-expands-global-footprint-for-drug-product-development-and-commercial-manufacturing/attachment/1154px-thermo_fisher_headquarters/ 2020-12-10T11:43:13+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-nbe-therapeutics/attachment/1200px-siedziba_boehringer_ingelheim_w_polsce-2/ 2020-12-11T05:48:45+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-to-acquire-myr/attachment/shaking-hands-3091906_640-1/ 2020-12-11T11:26:31+00:00 https://www.pharmaceutical-business-review.com/news/european-chmp-adopts-positive-opinion-for-dynavaxs-heplisav-b-vaccine-for-hepatitis-b/attachment/syringe-4544448_640-2/ 2020-12-11T11:34:12+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-alexion-pharmaceuticals/attachment/astra-10/ 2020-12-14T08:10:41+00:00 https://www.pharmaceutical-business-review.com/news/novartis-leqvio-hypercholesterolemia/attachment/novar-12/ 2020-12-14T10:33:56+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-and-biontech-celebrate-historic-first-authorisation-in-us-of-vaccine-to-prevent-covid-19/attachment/pfizer-28/ 2020-12-14T10:46:54+00:00 https://www.pharmaceutical-business-review.com/news/eqt-ix-recipharm/attachment/recipharm/ 2020-12-15T10:04:47+00:00 https://www.pharmaceutical-business-review.com/news/acceleron-sotatercept-pah/attachment/ec-building-4/ 2020-12-15T10:32:17+00:00 https://www.pharmaceutical-business-review.com/news/eureka-therapeutics-announces-preclinical-results-of-invisimask-human-antibody-nasal-spray-against-sars-cov-2-infection/attachment/eurek/ 2020-12-15T10:41:49+00:00 https://www.pharmaceutical-business-review.com/news/moderna-confirms-agreement-with-singapore-for-supply-of-mrna-vaccine-against-covid-19/attachment/virus-5768628_640/ 2020-12-15T10:54:23+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-prevail-therapeutics/attachment/eli-3/ 2020-12-16T08:30:10+00:00 https://www.pharmaceutical-business-review.com/news/xentria-announces-fda-orphan-drug-designation-for-xtmab-16-in-sarcoidosis/attachment/fda-drug-50/ 2020-12-16T10:44:14+00:00 https://www.pharmaceutical-business-review.com/news/fsd-pharma-fsd201/attachment/fsd-pharma-2/ 2020-12-16T10:47:59+00:00 https://www.pharmaceutical-business-review.com/news/cn-bio-university-of-melbourne-collaborate-to-advance-therapies-for-respiratory-complications-in-recovered-covid-19-patients/attachment/covid-19-4922384_640/ 2020-12-16T11:08:51+00:00 https://www.pharmaceutical-business-review.com/news/novartis-cadent-therapeutics/attachment/novartis-10/ 2020-12-17T09:07:52+00:00 https://www.pharmaceutical-business-review.com/news/neurogene-closes-115m-series-b-financing/attachment/pill-7/ 2020-12-17T10:27:54+00:00 https://www.pharmaceutical-business-review.com/news/gsk-active-lupus-nephritis/attachment/gsk-house-11/ 2020-12-18T05:24:52+00:00 https://www.pharmaceutical-business-review.com/news/moderna-receives-fda-advisory-committee-vote-supporting-emergency-use-for-modernas-vaccine-against-covid-19-in-us/attachment/corvirus-3/ 2020-12-18T11:33:50+00:00 https://www.pharmaceutical-business-review.com/news/moderna-covid-19-mrna-1273-fda-eua/attachment/coronavirus-4833616_640/ 2020-12-21T05:32:56+00:00 https://www.pharmaceutical-business-review.com/news/eib-launches-e50m-africa-pharmaceutical-manufacturing-initiative/attachment/7d50f58a-4515-42e1-a3f0-56716a3f2916/ 2020-12-21T11:03:08+00:00 https://www.pharmaceutical-business-review.com/news/servier-agios-oncology/attachment/servier/ 2020-12-22T08:22:36+00:00 https://www.pharmaceutical-business-review.com/suppliers/strategikon-pharma/whitepapers/dual-integrated-applications/attachment/2020_sponsor-edition-overview/ 2020-12-22T09:03:15+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-and-biontech-receive-authorisation-in-european-union-for-covid-19-vaccine/attachment/pfizer-29/ 2020-12-22T11:30:12+00:00 https://www.pharmaceutical-business-review.com/news/hepion-pharmaceuticals-covid-19/attachment/herma/ 2020-12-23T08:03:32+00:00 https://www.pharmaceutical-business-review.com/news/hyundai-bioscience-develops-injection-drug-for-potential-treatment-of-severe-cases-of-covid-19/attachment/hyund/ 2020-12-23T10:24:05+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-2/attachment/pfizer-30/ 2020-12-24T08:05:45+00:00 https://www.pharmaceutical-business-review.com/news/roche-phesgo-breast-cancer-2/attachment/rochebasel-8/ 2020-12-24T10:03:36+00:00 https://www.pharmaceutical-business-review.com/news/merck-announces-supply-agreement-with-us-for-initial-doses-of-investigational-biological-therapy-to-treat-covid-19/attachment/merck-5/ 2020-12-24T10:11:57+00:00 https://www.pharmaceutical-business-review.com/news/modag-initiates-first-in-patient-phase-1b-trial-for-anle138b-in-parkinsons-disease/attachment/test-214185_640-5/ 2020-12-24T11:17:20+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-covaxx-deal-covid-19-vaccine-ub-612/attachment/covid-19-4982910_640/ 2020-12-28T08:56:28+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-amphastars-generic-drug-hypoglycemia/attachment/diabetes-2424105_640/ 2020-12-29T13:14:13+00:00 https://www.pharmaceutical-business-review.com/news/moderna-south-korea-doses-covid-19-vaccine/attachment/injection-5722329_640/ 2020-12-30T07:17:39+00:00 https://www.pharmaceutical-business-review.com/news/moderna-south-korea-doses-covid-19-vaccine/attachment/syringe-4544448_640-1/ 2020-12-30T17:47:52+00:00 https://www.pharmaceutical-business-review.com/suppliers/experic/whitepapers/dry-powder-inhalation/attachment/experic-dpi-sell-sheet_digital_3-27-20_vf/ 2021-01-04T08:48:36+00:00 https://www.pharmaceutical-business-review.com/news/india-gives-restricted-emergency-use-approval-for-two-covid-19-vaccines/attachment/test-tube-5065426_640/ 2021-01-04T13:19:36+00:00 https://www.pharmaceutical-business-review.com/news/angelini-pharma-arvelle-therapeutics/attachment/arvelli/ 2021-01-05T07:32:30+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-arx788-fast-track-designation-for-her2-positive-metastatic-breast-cancer/attachment/fda-drug-51/ 2021-01-05T10:04:57+00:00 https://www.pharmaceutical-business-review.com/news/israeli-ministry-of-health-authorises-covid-19-vaccine-moderna-for-use-in-israel/attachment/syringe-5873159_640/ 2021-01-05T11:15:22+00:00 https://www.pharmaceutical-business-review.com/news/roche-tiragolumab-tecentriq-nsclc/attachment/roche-office-3/ 2021-01-06T07:14:28+00:00 https://www.pharmaceutical-business-review.com/news/lakepharma-akston-biosciences-covid-19/attachment/zarvaccine/ 2021-01-06T10:59:27+00:00 https://www.pharmaceutical-business-review.com/news/cure-pharmaceutical-receives-fda-approval-for-ind-application-for-erectile-dysfunction-product-curefilm-blue/attachment/fda-drug-52/ 2021-01-06T11:09:03+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-cell-culture-us/attachment/fuji/ 2021-01-07T06:57:32+00:00 https://www.pharmaceutical-business-review.com/news/moderna-covid-19-mrna-vaccine/attachment/modernavaccine/ 2021-01-07T11:42:36+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharmas-rhb-204-granted-fda-fast-track-designation-for-ntm-disease/attachment/fda-drug-53/ 2021-01-07T11:52:25+00:00 https://www.pharmaceutical-business-review.com/news/xencor-md-anderson-enter-collaboration-to-develop-novel-t-cell-engaging-bispecific-antibodies-for-potential-treatment-of-cancer/attachment/shaking-hands-3091906_640-5/ 2021-01-07T11:55:31+00:00 https://www.pharmaceutical-business-review.com/suppliers/bernhardt/attachment/bernhardt-logo-137/ 2021-01-07T12:00:59+00:00 https://www.pharmaceutical-business-review.com/news/bayer-curevac-covid-19/attachment/bayer-4/ 2021-01-08T07:54:21+00:00 https://www.pharmaceutical-business-review.com/news/am-pharma-covid-19/attachment/am-pharma/ 2021-01-08T10:18:45+00:00 https://www.pharmaceutical-business-review.com/news/inversago-pharma-receives-rare-paediatric-disease-designation-from-fda-for-inv-101-to-treat-prader-willi-syndrome/attachment/fda-drug-54/ 2021-01-08T10:28:28+00:00 https://www.pharmaceutical-business-review.com/news/teva-medincell-announce-positive-results-for-registration-trial-of-tv-46000-mdc-irm-for-patients-with-schizophrenia/attachment/1200px-tevacanada7/ 2021-01-08T11:20:35+00:00 https://www.pharmaceutical-business-review.com/news/affinivax-maps-vaccine/attachment/vaccine-2/ 2021-01-11T08:26:29+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-bnt162b2-vaccine-new-covid-strains/attachment/1200px-pfizer_world_headquarters_entrance/ 2021-01-11T10:38:51+00:00 https://www.pharmaceutical-business-review.com/news/celularity-and-gx-acquisition-announce-merger-agreement-to-create-publicly-listed-leader-in-allogeneic-cellular-therapy/attachment/cellular/ 2021-01-11T10:43:33+00:00 https://www.pharmaceutical-business-review.com/news/gsk-mmv-filing-for-kozenis-in-paediatric-populations-with-p-vivax-malaria-accepted-by-australian-tga/attachment/701px-glaxosmithkline_building_london_30_july_2007_cropped-2/ 2021-01-11T11:07:39+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-buy-biopharmaceutical-firm-kymab-for-up-to-1-45bn/attachment/sanofi-5/ 2021-01-12T07:52:37+00:00 https://www.pharmaceutical-business-review.com/news/covid-19-vaccine-sputnik-v-phase-2-trial-india/attachment/vaccination-1215279_640/ 2021-01-12T11:01:52+00:00 https://www.pharmaceutical-business-review.com/news/rocket-pharmaceuticals-announces-buildout-of-rd-and-manufacturing-facility-to-support-development-of-gene-therapy-pipeline/attachment/rock/ 2021-01-12T11:13:33+00:00 https://www.pharmaceutical-business-review.com/news/gsk-vir-covid-19/attachment/gsk-10/ 2021-01-13T08:25:36+00:00 https://www.pharmaceutical-business-review.com/news/amneal-to-acquire-substantially-all-of-kashiv-specialty-pharmaceuticals/attachment/amneal-2/ 2021-01-13T10:58:27+00:00 https://www.pharmaceutical-business-review.com/news/bayer-announces-fda-accepts-nda-and-grants-priority-review-for-finerenone-for-patients-with-ckd-and-t2d/attachment/leverkusen_kaiser-wilhelm-allee_0004/ 2021-01-13T11:16:44+00:00 https://www.pharmaceutical-business-review.com/news/ksq-takeda-immuno-oncology-therapies/attachment/692px-takeda-midosuji-bldg-01-2/ 2021-01-13T15:45:28+00:00 https://www.pharmaceutical-business-review.com/news/novartis-ligelizumab-urticaria/attachment/nova/ 2021-01-15T07:13:40+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-xalkori-approved-by-fda-for-alk-positive-anaplastic-large-cell-lymphoma-in-children-and-young-adults/attachment/pfizer-31/ 2021-01-15T10:32:36+00:00 https://www.pharmaceutical-business-review.com/news/newamsterdam-pharma-completes-196m-series-a-funding-for-phase-3-development-programme/attachment/conclusion-of-the-contract-3100563_640-1/ 2021-01-15T10:54:11+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-acquires-viral-vector-business-from-novasep-for-875m/attachment/architectural-details-of-new-thermo-fisher-scientific-hq-in-waltham-ma-02451-2/ 2021-01-18T11:13:04+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-receives-approval-to-conduct-phase-3-clinical-trial-for-sputnik-v-vaccine-in-india/attachment/virus-4937553_640/ 2021-01-18T11:39:17+00:00 https://www.pharmaceutical-business-review.com/news/imfinzi-approved-in-the-eu-for-less-frequent-fixed-dose-use-in-unresectable-non-small-cell-lung-cancer/attachment/1024px-astrazeneca_hq_in_cambridge_uk/ 2021-01-18T11:48:25+00:00 https://www.pharmaceutical-business-review.com/news/etana-launch-innovent-biologics-cancer-drug-byvasda-indonesia/attachment/innovent/ 2021-01-19T09:32:27+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/fluoroalkyl-ethers/attachment/enamine_fluoroalkyl-ethers_2021/ 2021-01-19T10:07:27+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/n-nitrosamines/attachment/enamine_n-nitrosamines_2020/ 2021-01-19T10:11:16+00:00 https://www.pharmaceutical-business-review.com/news/cure-genetics-boehringer-develop-aav-vectors-gene-therapy/attachment/cure-genetics/ 2021-01-19T10:40:09+00:00 https://www.pharmaceutical-business-review.com/news/novartis-gsk-genetic-diversity-research-africa/attachment/novartis-11/ 2021-01-20T09:51:39+00:00 https://www.pharmaceutical-business-review.com/news/gritstone-advancing-covid-19-vaccine-plans-trials/attachment/gritstone/ 2021-01-20T12:02:04+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-vaccine-in-vitro-study/attachment/covid-19-vaccine-5902833_640/ 2021-01-21T07:47:01+00:00 https://www.pharmaceutical-business-review.com/news/uae-approves-sputnik-v-vaccine-combat-covid-19/attachment/rdif/ 2021-01-22T06:42:17+00:00 https://www.pharmaceutical-business-review.com/news/akron-biotech-to-exclusively-manufacture-human-ab-serum-for-octapharma/attachment/akron-biotech/ 2021-01-22T06:50:39+00:00 https://www.pharmaceutical-business-review.com/industryopinion/qa-denish-pashuwala/attachment/shutterstock_1535828693/ 2021-01-22T08:41:01+00:00 https://www.pharmaceutical-business-review.com/industryopinion/new-pharma-fridges/attachment/matos-cloud-150-r-2/ 2021-01-22T08:44:37+00:00 https://www.pharmaceutical-business-review.com/industryopinion/cold-storage-products/attachment/shutterstock_658880020/ 2021-01-22T08:49:27+00:00 https://www.pharmaceutical-business-review.com/suppliers/ethicheck/whitepapers/rfid-refrigeration-solutions/attachment/ethicheck-matos-rfid-refrigeration-range-brochure-2/ 2021-01-22T08:55:14+00:00 https://www.pharmaceutical-business-review.com/news/humanigen-gains-barda-access-produce-lenzilumab/attachment/humanigen/ 2021-01-25T09:33:52+00:00 https://www.pharmaceutical-business-review.com/news/merck-discontinues-covid-19-vaccine-candidates/attachment/merck_office_upper_gwynedd_township_montgomery_county/ 2021-01-26T05:41:23+00:00 https://www.pharmaceutical-business-review.com/suppliers/owen-mumford-pbr-storefront/attachment/unisafe-2-25_025/ 2021-01-26T14:21:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/owen-mumford-pbr-storefront/attachment/300x300-logo/ 2021-01-26T14:22:11+00:00 https://www.pharmaceutical-business-review.com/suppliers/owen-mumford-pbr-storefront/attachment/owen-mumford-logo/ 2021-01-26T14:23:15+00:00 https://www.pharmaceutical-business-review.com/products/unisafe/attachment/unisafe-1ml-for-drugdelivery-2020/ 2021-01-26T14:28:46+00:00 https://www.pharmaceutical-business-review.com/products/autoject2-platform/attachment/autoject-v1/ 2021-01-26T14:29:59+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-china-approval-mild-asthma-symbicort-turbuhaler/attachment/fusion-x64-tiff-file/ 2021-01-27T08:28:32+00:00 https://www.pharmaceutical-business-review.com/news/us-dod-fund-humanetics-new-drug-against-covid-19/attachment/humanetics-2/ 2021-01-27T10:26:12+00:00 https://www.pharmaceutical-business-review.com/suppliers/gerresheimer/attachment/gerresheimer-logo/ 2021-01-27T15:09:12+00:00 https://www.pharmaceutical-business-review.com/news/existing-drug-offers-targeted-treatment-for-aggressive-breast-cancer/attachment/institute-of-cancer-research/ 2021-01-28T09:45:05+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-manufacture-pfizer-biontechs-covid-19-vaccine/attachment/sanofi-6/ 2021-01-28T11:46:15+00:00 https://www.pharmaceutical-business-review.com/news/ge-researchers-study-covid-19-impact-lungs/attachment/gehealthcare/ 2021-01-29T08:36:32+00:00 https://www.pharmaceutical-business-review.com/news/nih-study-severe-covid-19-pregnancy-complications/attachment/nih/ 2021-01-29T10:17:46+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-authorisation-covid-19-vaccine-europe/attachment/astrazeneca/ 2021-02-01T08:33:39+00:00 https://www.pharmaceutical-business-review.com/news/lilly-antibody-therapies-treating-covid-19/attachment/lily/ 2021-02-02T08:15:19+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-sta-buy-facility-bristol-myers-squibb/attachment/dcim100mediadji_0070-jpg/ 2021-02-03T08:12:44+00:00 https://www.pharmaceutical-business-review.com/news/ocugen-distribution-bharat-biotechs-covid-19-vaccine-in-us/attachment/ocugen/ 2021-02-03T10:48:43+00:00 https://www.pharmaceutical-business-review.com/news/gsk-curevac-collaboration-next-gen-covid-19-vaccines/attachment/injection-5722329_1280-2/ 2021-02-04T09:06:48+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-eua-application-covid-19-vaccine/attachment/virus-5768628_1280-1/ 2021-02-05T11:16:47+00:00 https://www.pharmaceutical-business-review.com/news/usfda-breyanzi-car-t-cell-therapy-adults/attachment/vaccination-5868322_1280/ 2021-02-08T10:28:08+00:00 https://www.pharmaceutical-business-review.com/news/usfda-breyanzi-car-t-cell-therapy-adults/attachment/1440px-mantle_cell_lymphoma_-_intermed_mag/ 2021-02-08T10:36:56+00:00 https://www.pharmaceutical-business-review.com/news/usfda-breyanzi-car-t-cell-therapy-adults/attachment/1440px-mantle_cell_lymphoma_-_intermed_mag-2/ 2021-02-08T10:39:28+00:00 https://www.pharmaceutical-business-review.com/news/usfda-breyanzi-car-t-cell-therapy-adults/attachment/jar-2338584_1280/ 2021-02-09T09:17:09+00:00 https://www.pharmaceutical-business-review.com/news/usfda-approves-libtayo-skin-cancer/attachment/1552px-melanoma/ 2021-02-10T08:42:55+00:00 https://www.pharmaceutical-business-review.com/news/usfda-approves-eua-bamlanivimab-etesevimab-combo-treat-covid-19-patients/attachment/coronavirus-4914026_1280-2/ 2021-02-10T16:16:26+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-signs-loi-idt-biologika-boost-europes-covid-19-vaccine-making-capability/attachment/vaccine-5895477_1280/ 2021-02-11T10:39:09+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-to-acquire-glaxosmithklines-cephalosporin-antibiotics-business/attachment/pill-1884775_1280/ 2021-02-12T11:40:42+00:00 https://www.pharmaceutical-business-review.com/news/oxford-university-commences-trial-on-covid-19-vaccine-on-children/attachment/oxford-vaccine-uk-children/ 2021-02-15T05:54:00+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/terminology-pharmacy/attachment/an_139_terminology_in_pharmacy_thermal_analysis_provides_the_overall_picture/ 2021-02-15T09:57:32+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/whitepapers/thermal-behavior-acetylsalicylic-acid/attachment/an_135_about_the_thermal_behavior_of_acetylsalicylic_acid_and_aspirin/ 2021-02-15T10:00:58+00:00 https://www.pharmaceutical-business-review.com/news/celltrion-healthcare-ec-authorisation-yuflyma/attachment/1280px-view_of_schuman_roundabout/ 2021-02-16T08:40:28+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-eu-covid-19-vaccine/attachment/pbr/ 2021-02-17T08:58:29+00:00 https://www.pharmaceutical-business-review.com/news/novartis-expanded-fda-indication-label-entresto/attachment/pbr-2/ 2021-02-17T15:27:13+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-200-million-covid-19-vaccine/attachment/pbr-1/ 2021-02-18T08:17:50+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-vir-biotechnology-covid-19-partnership/attachment/pbr-2-2/ 2021-02-18T15:26:28+00:00 https://www.pharmaceutical-business-review.com/news/usfda-grants-ftd-to-efanesoctocog-alfa-for-hemophilia-a-treatment/attachment/assorted-pills-by-joshua-coleman-on-unspl/ 2021-02-19T10:27:48+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-marketing-authorisation-hepatitis-b-vaccine/attachment/1280px-belgique_-_bruxelles_-_schuman_-_berlaymont_-_01/ 2021-02-22T08:43:51+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-imfinzi-indication-bladder-cancer/attachment/pbr-3/ 2021-02-23T07:52:30+00:00 https://www.pharmaceutical-business-review.com/news/usfda-priority-review-pfizers-ticovac/attachment/pbr-1-2/ 2021-02-24T08:27:12+00:00 https://www.pharmaceutical-business-review.com/news/ucb-partnership-microsoft-drug-development/attachment/pbr-2-3/ 2021-02-24T15:42:12+00:00 https://www.pharmaceutical-business-review.com/news/viiv-seeks-usfda-approval-expand-cabenuva/attachment/pbr-1-3/ 2021-02-25T07:58:20+00:00 https://www.pharmaceutical-business-review.com/news/moderna-global-covid-19-vaccine-capacity/attachment/pbr-2-4/ 2021-02-25T14:40:29+00:00 https://www.pharmaceutical-business-review.com/news/merck-signs-agreement-to-purchase-pandion-therapeutics/attachment/bioresearch-by-national-cancer-institute-on-unsplash/ 2021-02-26T09:45:03+00:00 https://www.pharmaceutical-business-review.com/news/merck-signs-agreement-to-purchase-pandion-therapeutics/attachment/merck_office_upper_gwynedd_township_montgomery_county-2/ 2021-02-26T09:52:48+00:00 https://www.pharmaceutical-business-review.com/news/ema-pfizer-opkos-somatrogon-marketing-application/attachment/pbr-4/ 2021-03-01T09:04:14+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-gubra-peptides-obesity/attachment/pbr-5/ 2021-03-02T08:37:49+00:00 https://www.pharmaceutical-business-review.com/news/deals/wuxi-apptec-oxgene-cell-gene-therapy-services/attachment/shaking-hands-3091906_640/ 2021-03-03T09:09:54+00:00 https://www.pharmaceutical-business-review.com/news/takeda-secures-global-rights-to-develop-and-commercialise-soticlestat/attachment/medicine-257349_1280/ 2021-03-04T08:49:40+00:00 https://www.pharmaceutical-business-review.com/news/deals/amgen-acquire-five-prime-therapeutics-1-9bn/attachment/pill-4897529_1280/ 2021-03-05T08:36:50+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnsons-covid-19-vaccine-authorisation-canada/attachment/pbr-6/ 2021-03-08T08:59:53+00:00 https://www.pharmaceutical-business-review.com/news/lilly-biolojic-antibody-therapies-diabetes/attachment/pbr-7/ 2021-03-09T09:15:22+00:00 https://www.pharmaceutical-business-review.com/news/japans-takeda-to-acquire-the-us-maverick-therapeutics/attachment/photo-by-national-cancer-institute-on-unsplash/ 2021-03-10T07:12:15+00:00 https://www.pharmaceutical-business-review.com/news/enveric-biosciences-signs-licensing-agreement-with-diverse-biotech/attachment/cannabis-by-david-gabric-on-unsplash/ 2021-03-11T07:50:25+00:00 https://www.pharmaceutical-business-review.com/news/niaid-grants-2-5m-to-12-institutes-for-bacteriophage-therapy-research/attachment/bacterial-colonies-by-adrian-lange-on-unsplash/ 2021-03-12T08:48:04+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-new-drug-application-for-lanadelumab-in-japan/attachment/takeda-injection-by-diana-polekhina-on-unsplash/ 2021-03-15T08:51:29+00:00 https://www.pharmaceutical-business-review.com/news/gilead-merck-agreement-to-develop-hiv-treatments-lenacapavir-and-islatravir/attachment/physician-and-patient-by-national-cancer-institute-on-unsplash/ 2021-03-16T05:51:05+00:00 https://www.pharmaceutical-business-review.com/news/usfda-grants-priority-review-to-mercks-nda-for-hif-2%ce%b1-inhibitor-belzutifan/attachment/kidney-by-robina-weermeijer-on-unsplash/ 2021-03-17T06:39:29+00:00 https://www.pharmaceutical-business-review.com/news/contracts/astrazeneca-to-deliver-500000-more-doses-of-azd7442-to-the-us/attachment/covid019-vaccination-by-steven-cornfield-on-unsplash/ 2021-03-17T11:15:48+00:00 https://www.pharmaceutical-business-review.com/news/usfda-extends-review-period-for-abbvies-snda-of-upadacitinib/attachment/cristina-gottardi-q3fihxq-13m-unsplash/ 2021-03-18T07:53:23+00:00 https://www.pharmaceutical-business-review.com/news/ambrx-gets-orphan-drug-designation-gastric-cancer-treatment-arx788/attachment/orphan-drug-by-anastasiia-ostapovych-on-unsplash/ 2021-03-18T14:29:14+00:00 https://www.pharmaceutical-business-review.com/news/deals/boston-pharmaceuticals-signs-three-year-agreement-with-gsk/attachment/pharma-by-laurynas-mereckas-on-unsplash/ 2021-03-19T08:20:39+00:00 https://www.pharmaceutical-business-review.com/news/anima-signs-new-strategic-collaboration-deal-with-takeda/attachment/anima-by-national-cancer-institute-on-unsplash/ 2021-03-19T13:43:48+00:00 https://www.pharmaceutical-business-review.com/news/usfda-approves-janssens-ponvory-for-treatment-of-multiple-sclerosis/attachment/mutiple-sclerosis-by-matteo-badini-on-unsplash/ 2021-03-22T08:24:03+00:00 https://www.pharmaceutical-business-review.com/news/dyadic-medytox-co-develop-covid-19-variant-fighting-vaccines/attachment/covid-vaccine-by-macau-photo-agency-on-unsplash/ 2021-03-23T08:18:26+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-zealand-pharmas-zegalogue-for-hypoglycemia-treatment/attachment/hypoglycemia-by-diabetesmagazijn-nl-on-unsplash/ 2021-03-23T14:32:43+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/md-img-pharmatech-page-tile-image-spectramax-i3x_image-1/ 2021-03-23T16:32:14+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/md-img-pharmatech-page-tile-image-spectramax-id3_image-3/ 2021-03-23T16:32:22+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/md-img-pharmatech-page-tile-image-spectramax-id5_image-2/ 2021-03-23T16:32:36+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/molecular-device-lead/ 2021-03-23T16:32:43+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/molecular-device-logo/ 2021-03-23T16:32:51+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/spectramax-abs-plus-1200x675/ 2021-03-23T16:33:12+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/spectramax-i3x-multi-mode-microplate-reader-1200x675/ 2021-03-23T16:33:30+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/spectramax-id5-multi-mode-microplate-reader-1200x675/ 2021-03-23T16:33:42+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/spectramax-m-series-multi-mode-microplate-reader-1220x675/ 2021-03-23T16:33:59+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/spectratest-validation-plates-1200x675/ 2021-03-23T16:34:10+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/id3-multi-mode-microplate-reader-1200-x-675/ 2021-03-23T16:34:20+00:00 https://www.pharmaceutical-business-review.com/suppliers/molecular-devices/attachment/molecular-device-logo-2/ 2021-03-23T16:35:17+00:00 https://www.pharmaceutical-business-review.com/news/fidia-farmaceutici-sanofis-anti-inflammatory-drugs/attachment/pbr-8/ 2021-03-24T09:12:07+00:00 https://www.pharmaceutical-business-review.com/news/ucla-led-lab-study-identifies-potential-drug-to-treat-sars-cov-2-virus/attachment/corona-5174671_1280/ 2021-03-25T10:41:55+00:00 https://www.pharmaceutical-business-review.com/news/us-nih-sars-cov-2-virus-infects-cells-mouth/attachment/20210325-mouth/ 2021-03-26T09:17:57+00:00 https://www.pharmaceutical-business-review.com/news/ema-gilead-sciences-breast-cancer-therapy/attachment/1280px-vivaldigebouw_2019-10-24_1/ 2021-03-26T12:45:55+00:00 https://www.pharmaceutical-business-review.com/news/japan-bristol-myers-squibbs-b-cell-lymphoma/attachment/1440px-mantle_cell_lymphoma_-_intermed_mag-3/ 2021-03-26T13:47:04+00:00 https://www.pharmaceutical-business-review.com/news/usfda-abecma-relapsed-refractory-multiple-myeloma/attachment/national-cancer-institute-ltlb51-xgp4-unsplash/ 2021-03-29T08:18:12+00:00 https://www.pharmaceutical-business-review.com/news/usfda-sends-crl-to-mercks-sbla-regarding-keytruda/attachment/breast-cancer-by-angiola-harry-on-unsplash/ 2021-03-30T08:19:14+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/snap-reagents/attachment/enamine_snap_reagents/ 2021-03-30T08:36:32+00:00 https://www.pharmaceutical-business-review.com/news/amgen-biopharmaceutical-rodeo-therapeutics/attachment/1533px-amgenheadquarters/ 2021-03-31T08:51:30+00:00 https://www.pharmaceutical-business-review.com/news/takeda-otc-non-core-assets-orifarm/attachment/shaking-hands-3091906_1280/ 2021-04-01T09:02:13+00:00 https://www.pharmaceutical-business-review.com/news/piramal-apis-hemmo-pharmaceuticals/attachment/50999907705_389c784bde_k/ 2021-04-01T10:23:07+00:00 https://www.pharmaceutical-business-review.com/contractors/gerresheimer/news/sustainability-targets/attachment/gerresheimer-graphic/ 2021-04-01T11:51:27+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-usfda-review-period-rinvoq-snda/attachment/2474512963_5583007b7c_k/ 2021-04-05T09:01:03+00:00 https://www.pharmaceutical-business-review.com/news/anixa-and-ontochem-enter-next-stage-of-covid-19-anti-viral-therapy-development/attachment/martin-sanchez-vhjsgkmefkk-unsplash-1/ 2021-04-06T07:45:50+00:00 https://www.pharmaceutical-business-review.com/news/antengene-nmpa-approval-ind-atg-019/attachment/national-cancer-institute-qmmkpj557iq-unsplash/ 2021-04-06T09:08:27+00:00 https://www.pharmaceutical-business-review.com/news/ab-science-university-of-chicago-covid-19-treatment/attachment/2880px-university_of_chicago_july_2013_19_main_quadrangles/ 2021-04-07T10:15:12+00:00 https://www.pharmaceutical-business-review.com/news/usfda-eli-lilly-incytes-snda-baricitinib/attachment/2880px-eli_lilly_corporate_center_indianapolis_indiana_usa/ 2021-04-07T15:09:16+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-presents-applications-to-fda-and-ema-for-approval-of-skyrizi-in-psoriatic-arthritis/attachment/steven-hwg-zbsdrthiim4-unsplash/ 2021-04-08T07:36:54+00:00 https://www.pharmaceutical-business-review.com/news/biogen-and-bio-thera-solutions-announce-commercialisation-and-license-agreement-for-bat1806/attachment/board-4862180_1920/ 2021-04-09T09:19:44+00:00 https://www.pharmaceutical-business-review.com/news/deals/sanofi-acquires-tidal-therapeutics/attachment/michael-schiffer-13uugsl9q7a-unsplash/ 2021-04-12T08:54:23+00:00 https://www.pharmaceutical-business-review.com/news/airway-therapeutics-ind-application-at-100-covid-19/attachment/coronavirus-13-april-2021/ 2021-04-13T09:00:11+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-secures-eua-for-sputnik-v-in-india/attachment/coronavirus-5935581_1920/ 2021-04-14T06:55:32+00:00 https://www.pharmaceutical-business-review.com/news/trodelvy-granted-accelerated-approval-by-usfda-for-metastatic-urothelial-cancer/attachment/doctor-5707722_1920/ 2021-04-14T14:29:15+00:00 https://www.pharmaceutical-business-review.com/news/scineuro-and-eli-lilly-sign-exclusive-license-agreement-for-alpha-synuclein-in-greater-china/attachment/jesse-orrico-rmwtvqn5rzu-unsplash/ 2021-04-15T07:00:15+00:00 https://www.pharmaceutical-business-review.com/suppliers/willy-a-bachofen-ag-maschinenfabrik/attachment/img_2342-small/ 2021-04-15T10:32:27+00:00 https://www.pharmaceutical-business-review.com/products/dyno-mill-pharma/attachment/wab_3d_shaker_mixer_turbula_de_en_fr/ 2021-04-15T10:34:20+00:00 https://www.pharmaceutical-business-review.com/products/dyno-mill-pharma/attachment/wab_agitator_bead_mill_dyno-mill_ecm-ap_en/ 2021-04-15T10:34:21+00:00 https://www.pharmaceutical-business-review.com/products/dyno-mill-pharma/attachment/wab-group_pharma-technologies_en/ 2021-04-15T10:34:22+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-grants-bristol-myers-squibb-approval-for-opdivo-to-treat-rcc/attachment/national-cancer-institute-sbw1t0yfz8k-unsplash/ 2021-04-15T22:33:16+00:00 https://www.pharmaceutical-business-review.com/suppliers/willy-a-bachofen-ag-maschinenfabrik/attachment/img_2342-small-2/ 2021-04-16T09:02:57+00:00 https://www.pharmaceutical-business-review.com/news/gsk-and-vir-announce-ema-review-of-vir-7831-for-early-treatment-of-covid-19/attachment/virus-4931227_1920/ 2021-04-16T09:05:52+00:00 https://www.pharmaceutical-business-review.com/news/us-clearance-granted-for-astrazenecas-proposed-acquisition-of-alexion/attachment/check-3183195_1920/ 2021-04-19T09:03:39+00:00 https://www.pharmaceutical-business-review.com/contractors/tosoh-bioscience/news/tskgel-hplc-column/attachment/fcr-affinity-receptors/ 2021-04-19T15:49:38+00:00 https://www.pharmaceutical-business-review.com/news/second-indication-of-sarclisa-for-relapsed-multiple-myeloma-approved-by-ec/attachment/anton-oemojnqyye4-unsplash/ 2021-04-20T08:10:02+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-resume-covid-19-vaccine-roll-out-in-europe-after-ema-review/attachment/steven-cornfield-ntvfmrmmxwy-unsplash/ 2021-04-21T09:02:29+00:00 https://www.pharmaceutical-business-review.com/news/claritas-cmax-clinical-phase-1-r-107-clinical-study/attachment/national-cancer-institute-folo2hdmsa4-unsplash/ 2021-04-22T12:06:03+00:00 https://www.pharmaceutical-business-review.com/news/vertex-obsidian-partner-gene-editing-medicines/attachment/nih-2/ 2021-04-23T08:22:18+00:00 https://www.pharmaceutical-business-review.com/news/study-parp-inhibitors-kill-cancer-cells-pbrm1-gene/attachment/patient-and-clinician_945x532/ 2021-04-26T09:54:07+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/scaling-up-production/attachment/for_use_26-4-21-4978-nsf-hs-pbr-key-tips-for-scaling-up-prod-of-pharma_emailer-image-600x250px-v1/ 2021-04-27T10:13:39+00:00 https://www.pharmaceutical-business-review.com/news/emas-chmp-eu-astrazeneca-mercks-selumetinib/attachment/original/ 2021-04-27T10:44:26+00:00 https://www.pharmaceutical-business-review.com/suppliers/rws/attachment/rws-logo/ 2021-04-27T15:16:36+00:00 https://www.pharmaceutical-business-review.com/suppliers/rws/attachment/life-science-header-640x320-c_tcm228-157677/ 2021-04-27T15:17:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-licences-indian-companies-molnupiravir/attachment/test-tube-5065426_1280/ 2021-04-28T08:00:29+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-amplyx-pharmaceuticals/attachment/shaking-hands-3091906_1280-2/ 2021-04-29T09:00:18+00:00 https://www.pharmaceutical-business-review.com/news/canbridge-mirum-maralixibat-greater-china/attachment/document-428334_1280/ 2021-04-30T10:54:03+00:00 https://www.pharmaceutical-business-review.com/news/who-emergency-use-modernas-covid-19-vaccine/attachment/syringe-5873159_1280/ 2021-05-03T08:09:57+00:00 https://www.pharmaceutical-business-review.com/news/revive-ucsf-bucillamine-severe-covid-19/attachment/coronavirus-5086678_1280/ 2021-05-04T08:03:12+00:00 https://www.pharmaceutical-business-review.com/news/viiv-rolling-submission-cabotegravir-prevent-hiv/attachment/hiv-1903371_1280/ 2021-05-05T08:32:49+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-canada-approval-for-adolescents/attachment/vaccine-6158184_1280/ 2021-05-06T07:19:21+00:00 https://www.pharmaceutical-business-review.com/news/russia-single-dose-covid-19-vaccine-sputnik-light/attachment/vaccine-6109246_1280/ 2021-05-07T08:19:37+00:00 https://www.pharmaceutical-business-review.com/news/indias-dcgi-oxygen-dependence-lowering-covid-19-drug/attachment/coronavirus-4932607_1280/ 2021-05-10T09:37:15+00:00 https://www.pharmaceutical-business-review.com/news/fda-pfizer-biontech-vaccine-adolescents/attachment/vaccinate-4833616_1280/ 2021-05-11T07:22:33+00:00 https://www.pharmaceutical-business-review.com/news/lilly-mina-therapeutics-drug-candidates/attachment/1024px-eli_lilly_corporate_center_indianapolis_indiana_usa-3/ 2021-05-12T09:50:33+00:00 https://www.pharmaceutical-business-review.com/news/cdr-agrees-acquire-udg-healthcare/attachment/pill-1884775_1280-1/ 2021-05-13T10:47:38+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-license-anti-bcma-car-t-prg1801-india/attachment/nurse-4967171_1280/ 2021-05-14T03:31:02+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-pilot-russias-sputnik-v-vaccine-india/attachment/vaccine-5895477_1280-2/ 2021-05-17T08:01:06+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-acquire-vigene-biosciences/attachment/dna-3889611_1280/ 2021-05-18T08:56:18+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/maxims-early-phase-trials/attachment/sgs-hn-maxims-whitepaper-en/ 2021-05-18T15:56:43+00:00 https://www.pharmaceutical-business-review.com/news/bms-cancer-therapy-deal-agenus/attachment/4353113087_4d19c3a402_c/ 2021-05-19T09:30:09+00:00 https://www.pharmaceutical-business-review.com/news/exscientia-bms-deal/attachment/ai-2005/ 2021-05-20T06:52:35+00:00 https://www.pharmaceutical-business-review.com/news/gsk-sells-stake-innoviva-392m/attachment/gsk-11/ 2021-05-21T06:41:55+00:00 https://www.pharmaceutical-business-review.com/news/japan-astrazeneca-modernas-covid-19-vaccines/attachment/vaccinate-4833616_1280-2/ 2021-05-24T08:46:07+00:00 https://www.pharmaceutical-business-review.com/news/xeris-pharmaceuticals-strongbridge-biopharma/attachment/shaking-hands-3091906_1280-3/ 2021-05-25T08:32:16+00:00 https://www.pharmaceutical-business-review.com/news/pieris-genentech-respiratory-ophthalmology-therapies/attachment/hand-3632914_1280/ 2021-05-26T08:50:02+00:00 https://www.pharmaceutical-business-review.com/products/valex-potent-filter-system/attachment/valex-filter-system/ 2021-05-27T10:21:31+00:00 https://www.pharmaceutical-business-review.com/products/valex-potent-filter-system/attachment/valex-potent-brochure/ 2021-05-27T10:21:47+00:00 https://www.pharmaceutical-business-review.com/news/carlyle-acquire-vectura-for-1-4bn/attachment/conclusion-of-the-contract-3100563_1280/ 2021-05-27T10:29:31+00:00 https://www.pharmaceutical-business-review.com/products/magnexflo/attachment/magnexflo-brochure/ 2021-05-27T10:31:14+00:00 https://www.pharmaceutical-business-review.com/products/magnexflo/attachment/magnexflo-filtration-system/ 2021-05-27T10:31:14+00:00 https://www.pharmaceutical-business-review.com/products/bioklaris/attachment/ds-bcm-520-pharma-en/ 2021-05-27T10:36:18+00:00 https://www.pharmaceutical-business-review.com/products/bioklaris/attachment/ds-bioklaris-es-water/ 2021-05-27T10:38:37+00:00 https://www.pharmaceutical-business-review.com/products/beapure/attachment/beapure-logo/ 2021-05-27T10:46:49+00:00 https://www.pharmaceutical-business-review.com/products/granfilter-bea/attachment/ds-granfilter-bea-en/ 2021-05-27T10:51:25+00:00 https://www.pharmaceutical-business-review.com/products/granfilter-bea/attachment/granfilter/ 2021-05-27T10:53:54+00:00 https://www.pharmaceutical-business-review.com/news/prestige-consumer-healthcare-akorns-brands-230m/attachment/eye-2340806_1280/ 2021-05-28T07:12:02+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-eu-authorisation/attachment/virus-5768628_1280/ 2021-05-31T07:41:29+00:00 https://www.pharmaceutical-business-review.com/news/samsung-biologics-mrna-vaccine-production-line/attachment/20210531180621baa63092e-ae4c-4262-ad18-c3b065dc7e5c/ 2021-06-01T08:44:37+00:00 https://www.pharmaceutical-business-review.com/news/amgen-kyowa-kirin-antibody-atopic-dermatitis/attachment/1533px-amgenheadquarters-2/ 2021-06-02T09:15:04+00:00 https://www.pharmaceutical-business-review.com/suppliers/linical/attachment/linical-therapeutic-expertise/ 2021-06-02T10:24:39+00:00 https://www.pharmaceutical-business-review.com/suppliers/linical/attachment/linical-logo/ 2021-06-02T10:29:26+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-constellation-pharmaceuticals-1-7bn/attachment/dji_0263/ 2021-06-03T09:48:16+00:00 https://www.pharmaceutical-business-review.com/news/centivax-collaboration-us-nmrc-covid-19-antibody/attachment/vaccine-5926664_1280/ 2021-06-03T13:35:17+00:00 https://www.pharmaceutical-business-review.com/news/merck-completion-organon-spinoff/attachment/kenilworth-site-photos/ 2021-06-04T09:02:52+00:00 https://www.pharmaceutical-business-review.com/suppliers/linical/whitepapers/cro-drug-development-services/attachment/linical-overview-v4/ 2021-06-04T14:00:55+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-uk-approval/attachment/hakan-nural-z2n-r7pg6km-unsplash/ 2021-06-07T08:54:07+00:00 https://www.pharmaceutical-business-review.com/news/biogen-eisai-fda-alzheimers-drug-aduhelm/attachment/mental-3436232_1280/ 2021-06-08T09:03:16+00:00 https://www.pharmaceutical-business-review.com/news/indivior-aelis-cannabis-use-disorder/attachment/seedling-1062908_1280/ 2021-06-09T09:38:55+00:00 https://www.pharmaceutical-business-review.com/news/merck-1-7-million-courses-molnupiravir-us/attachment/kenilworth-site-photos-2/ 2021-06-10T09:28:57+00:00 https://www.pharmaceutical-business-review.com/news/ocugen-approval-covaxin-us/attachment/vaccinate-4833616_1280-3/ 2021-06-11T09:48:43+00:00 https://www.pharmaceutical-business-review.com/news/emas-chmp-modernas-covid-19-vaccine/attachment/virus-5768628_1280-2/ 2021-06-14T08:04:57+00:00 https://www.pharmaceutical-business-review.com/news/gsk-iteos-therapeutics-co-develop-cancer-drug/attachment/mitosis-3876669_1280/ 2021-06-15T07:36:49+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-fda-approval-stratagraft/attachment/stratagraft/ 2021-06-16T08:02:26+00:00 https://www.pharmaceutical-business-review.com/news/novartis-prostate-cancer-drug-breakthrough-status/attachment/novartis_1706/ 2021-06-17T08:05:03+00:00 https://www.pharmaceutical-business-review.com/news/danaher-acquire-aldevron-9-6bn/attachment/microbiology-1806/ 2021-06-18T07:55:46+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-belgium-court-vaccine-doses-eu/attachment/vaccine-5926664_1280-2/ 2021-06-21T08:54:07+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-horizon-collaboration-rnai-therapeutic/attachment/shaking-hands-3091906_1280-4/ 2021-06-22T08:51:03+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-modernas-covid-19-vaccine/attachment/vaccine-5942321_1280/ 2021-06-23T07:41:43+00:00 https://www.pharmaceutical-business-review.com/news/viiv-halozyme-develop-hiv-medicines/attachment/hiv-1903373_1280/ 2021-06-23T12:13:32+00:00 https://www.pharmaceutical-business-review.com/news/gsk-plans-consumer-healthcare-spin-off/attachment/gsk-2406/ 2021-06-24T07:58:37+00:00 https://www.pharmaceutical-business-review.com/news/eisai-biogen-alzheimers-drug-breakthrough-status/attachment/beta-amyloid/ 2021-06-24T09:18:18+00:00 https://www.pharmaceutical-business-review.com/news/fda-emergency-use-actemra-covid/attachment/roche-2506/ 2021-06-25T06:45:32+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-acquire-teneoone-lead-drug/attachment/abbvieuse/ 2021-06-25T10:15:56+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-230m-settle-opioid-claims/attachment/jar-2338584_1280-2/ 2021-06-28T08:08:03+00:00 https://www.pharmaceutical-business-review.com/news/stada-sanofis-consumer-healthcare-brands/attachment/20210628_press_release_stada_further_grows_european_consumer_healthcare_portfolio_609x571/ 2021-06-29T09:04:31+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-mrna-center-of-excellence-covid-19-vaccines/attachment/virus-5768628_1280-3/ 2021-06-30T08:46:08+00:00 https://www.pharmaceutical-business-review.com/news/gic-invests-1bn-grifols-biomat-usa/attachment/plasma-2753321_1280/ 2021-07-01T09:20:47+00:00 https://www.pharmaceutical-business-review.com/news/ifc-713m-aspen-covid-19-vaccine/attachment/vaccine-6109246_1280-2/ 2021-07-01T13:15:30+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/pharmaceutical-legislation-subscription/attachment/cpd-subcription-service-september/ 2021-07-01T14:46:59+00:00 https://www.pharmaceutical-business-review.com/news/philip-morris-acquire-fertin-pharma-812-8m/attachment/shaking-hands-3091906_1280-5/ 2021-07-02T09:18:07+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/analogues-piperidine-drug-design/attachment/enamine_analogues-of-piperidine_2021/ 2021-07-02T13:42:47+00:00 https://www.pharmaceutical-business-review.com/news/seres-nestle-oral-microbiome-therapeutic-canada-us/attachment/clostridium_difficile_colonies/ 2021-07-02T14:49:47+00:00 https://www.pharmaceutical-business-review.com/news/gsk-alector-antibodies-neurodegenerative-diseases/attachment/brain-1787622_1280/ 2021-07-05T09:04:28+00:00 https://www.pharmaceutical-business-review.com/news/mexico-produces-sputnik-v-covid-19-vaccine/attachment/coronavirus-5935581_1280/ 2021-07-06T09:56:01+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-clearance-alexion-acquisition/attachment/astrazeneca-plc/ 2021-07-07T09:20:23+00:00 https://www.pharmaceutical-business-review.com/news/eureka-msk-license-agreement-sanofi-gprc5d-binder/attachment/mitosis-3876669_1280-2/ 2021-07-07T13:41:37+00:00 https://www.pharmaceutical-business-review.com/news/altesa-license-agreement-vaxart-vapendavir/attachment/8405362662_a5f2951f27_c/ 2021-07-08T09:12:57+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-grants-priority-review-to-tezepelumab-to-treat-asthma-patients/attachment/fusion-x64-tiff-file-2/ 2021-07-08T14:50:51+00:00 https://www.pharmaceutical-business-review.com/news/verge-genomics-eli-lilly-develop-als-therapies/attachment/alice_1/ 2021-07-09T09:04:30+00:00 https://www.pharmaceutical-business-review.com/news/philip-morris-vectura-group-1-2bn/attachment/17-07-24_pmi_day05_09722/ 2021-07-12T08:46:22+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-prothenas-attr-amyloidosis-programme/attachment/conclusion-of-the-contract-3100563_1280-2/ 2021-07-13T08:52:46+00:00 https://www.pharmaceutical-business-review.com/news/rdif-sii-sputnik-v-covid-19-vaccine-india/attachment/daniel-schludi-zemri9vo71o-unsplash/ 2021-07-14T09:26:08+00:00 https://www.pharmaceutical-business-review.com/news/prime-medicine-315m-funding-editing-platform/attachment/gout-2870583_1280/ 2021-07-14T13:41:19+00:00 https://www.pharmaceutical-business-review.com/news/lilly-remaining-shares-protomer-technologies/attachment/1440px-eli_lilly_corporate_center_indianapolis_indiana_usa/ 2021-07-15T09:58:49+00:00 https://www.pharmaceutical-business-review.com/suppliers/cbdepot/whitepapers/certification-ingredients/attachment/21-07-015_cbdepot-progresses-in-certification-of-its-ingredients-for-use-in-organic-and-natural-cosmetics/ 2021-07-16T09:25:02+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-1-8bn-expand-research-facilities/attachment/1440px-new_eastview_office_bldg_jeh/ 2021-07-16T09:32:28+00:00 https://www.pharmaceutical-business-review.com/news/gsk-biotech-life-sciences-campus-stevenage/attachment/glaxosmithkline_building_london_30_july_2007_cropped/ 2021-07-19T09:50:25+00:00 https://www.pharmaceutical-business-review.com/news/partners-group-pharmathen-bc-partners-1-9bn/attachment/pill-1884775_1280-2/ 2021-07-20T09:21:41+00:00 https://www.pharmaceutical-business-review.com/news/japan-roches-ronapreve-covid-19-treatment/attachment/towfiqu-barbhuiya-fsveqeiotpo-unsplash/ 2021-07-21T08:59:07+00:00 https://www.pharmaceutical-business-review.com/news/three-us-drug-distributors-1-18bn-opioid-cas/attachment/national-cancer-institute-2g9uimevkvk-unsplash/ 2021-07-21T13:59:42+00:00 https://www.pharmaceutical-business-review.com/news/biovac-pfizer-biontech-covid-19-vaccine/attachment/hakan-nural-yzrh-rzwios-unsplash/ 2021-07-22T09:20:28+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-acquisition-biopharmaceutical-firm-alexion/attachment/original-2/ 2021-07-22T13:04:26+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-and-arvinas-to-jointly-develop-and-commercialise-breast-cancer-drug/attachment/national-cancer-institute-w2ovh2w2kpo-unsplash/ 2021-07-23T09:45:26+00:00 https://www.pharmaceutical-business-review.com/news/fda-keytruda-lenvima-combination-endometrial-cancer/attachment/olympus-digital-camera-2/ 2021-07-23T13:12:24+00:00 https://www.pharmaceutical-business-review.com/news/emas-chmp-eu-modernas-covid-19-vaccine/attachment/vaccine-6165772_1280/ 2021-07-26T09:51:07+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-acquire-life-science-antibodies-biolegend/attachment/1540px-perkinelmer_headquarters/ 2021-07-27T08:15:43+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/deuterium-containing-building-blocks/attachment/enamine_deuterium-containing-bb/ 2021-07-27T09:36:53+00:00 https://www.pharmaceutical-business-review.com/news/amgen-acquire-biotechnology-firm-teneobio/attachment/thousand-oaks_ca_10/ 2021-07-28T08:18:40+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-calico-age-related-disease-therapies/attachment/abbviehqe_004-2/ 2021-07-28T12:35:30+00:00 https://www.pharmaceutical-business-review.com/news/gsk-vir-biotechnology-covid-19-drug-eu/attachment/22720111227_2a042d40c2_k/ 2021-07-29T08:49:17+00:00 https://www.pharmaceutical-business-review.com/news/deep-genomics-180m-ai-platform-rna-therapies/attachment/dna-4068826_1280/ 2021-07-29T13:04:09+00:00 https://www.pharmaceutical-business-review.com/news/usfda-baricitinib-emergency-use-covid-19-patients/attachment/1440px-eli_lilly_corporate_center_indianapolis_indiana_usa-2/ 2021-07-30T08:59:57+00:00 https://www.pharmaceutical-business-review.com/news/takeda-frazier-hillevax-norovirus-vaccine/attachment/syringe-5904302_1280/ 2021-07-30T13:18:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/contract-immune-monitoring-and-research/whitepapers/affinity-tag-coating/attachment/cells-10-01843/ 2021-08-01T15:23:01+00:00 https://www.pharmaceutical-business-review.com/news/usfda-regen-cov-post-exposure-prophylaxis/attachment/mufid-majnun-cm1au42fnrg-unsplash/ 2021-08-02T09:19:40+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-exicure-co-develop-neurodegenerative-diseases/attachment/fakurian-design-58z17lnvs4u-unsplash/ 2021-08-03T09:17:37+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-mrna-partner-translate-bio/attachment/shaking-hands-3091906_1280-6/ 2021-08-04T09:12:03+00:00 https://www.pharmaceutical-business-review.com/news/amgen-drug-substance-manufacturing-plant/attachment/flag_to_042/ 2021-08-04T13:05:57+00:00 https://www.pharmaceutical-business-review.com/news/european-buy-200-million-novavax-covid-19-vaccine/attachment/daniel-schludi-zemri9vo71o-unsplash-2/ 2021-08-05T09:03:42+00:00 https://www.pharmaceutical-business-review.com/news/bayer-vividion-therapeutic-for-1-5bn/attachment/1440px-leverkusen_kaiser-wilhelm-allee_0004/ 2021-08-05T13:49:25+00:00 https://www.pharmaceutical-business-review.com/news/nih-study-enrolment-brii-biosciences-covid-19-antibodies/attachment/corona-5174671_1920/ 2021-08-06T08:39:28+00:00 https://www.pharmaceutical-business-review.com/news/akston-dosing-phase-ii-trial-covid-19-vaccine/attachment/vaccine-5926664_1920/ 2021-08-06T08:48:17+00:00 https://www.pharmaceutical-business-review.com/news/india-approves-jjs-single-dose-covid-19-vaccine/attachment/vaccine-5895477_1920/ 2021-08-09T09:08:24+00:00 https://www.pharmaceutical-business-review.com/contractors/butterworth-laboratories-ltd-pbr/news/nps-amino-acid-analysis/attachment/butterworth-nps/ 2021-08-09T10:11:41+00:00 https://www.pharmaceutical-business-review.com/news/inovio-covid-19-vaccine-prime-boost-trials-china/attachment/virus-5768628_1280-3-2/ 2021-08-10T09:43:46+00:00 https://www.pharmaceutical-business-review.com/news/moderna-mrna-vaccine-manufacturing-canada/attachment/ian-hutchinson-iuiktpnhoba-unsplash/ 2021-08-11T09:04:55+00:00 https://www.pharmaceutical-business-review.com/news/usfda-priority-review-mercks-keytruda/attachment/robina-weermeijer-szkjhypq28-unsplash/ 2021-08-11T13:21:55+00:00 https://www.pharmaceutical-business-review.com/news/fda-astrazeneca-fibrogens-roxadustat-ckd-anaemia/attachment/original-3/ 2021-08-12T08:24:15+00:00 https://www.pharmaceutical-business-review.com/news/gentibio-157m-series-a-funding-round/attachment/allergy-1738191_1280/ 2021-08-12T13:27:26+00:00 https://www.pharmaceutical-business-review.com/news/usfda-covid-19-vaccine-doses-weak-immune-systems/attachment/covid-19-vaccine-5902833_1280/ 2021-08-13T09:38:43+00:00 https://www.pharmaceutical-business-review.com/news/modernas-covid-19-vaccine-antibodies-variants/attachment/vaccine-6165772_1280-2/ 2021-08-13T13:37:25+00:00 https://www.pharmaceutical-business-review.com/news/merck-rolling-submission-molnupiravir-covid-19-patients/attachment/kenilworth-site-photos-3/ 2021-08-16T09:01:08+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-data-covid-19-booster-authorisation/attachment/jesse-paul-z5bx31kq2pw-unsplash/ 2021-08-17T10:39:41+00:00 https://www.pharmaceutical-business-review.com/news/gritstone-cepi-covid-19-vaccine/attachment/49679608341_f1aba40db1_k/ 2021-08-18T08:29:27+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-two-pipeline-autoimmune-kidney-diseases/attachment/pills-3673645_1280/ 2021-08-18T14:08:46+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-boehringer-eli-lilly-jardiance/attachment/48710782226_966417d9e7_h/ 2021-08-19T07:34:41+00:00 https://www.pharmaceutical-business-review.com/news/somalogic-twist-bioscience-novel-antibodies/attachment/virus-5741636_1280/ 2021-08-19T14:28:52+00:00 https://www.pharmaceutical-business-review.com/news/nice-midostaurin-advanced-systemic-mastocytosis/attachment/red-blood-cell-4256710_1280/ 2021-08-20T09:51:33+00:00 https://www.pharmaceutical-business-review.com/news/ec-bristol-myers-anti-bcma-car-t-cell-treatment/attachment/vaccination-2722937_1280/ 2021-08-23T08:42:04+00:00 https://www.pharmaceutical-business-review.com/news/india-eua-zydus-cadilas-zycov-d-covid-19/attachment/zycov-d-packshot/ 2021-08-23T08:49:27+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-pfizer-biontechs-covid-19-vaccine/attachment/covid-19-vaccine-5902833_1280-2/ 2021-08-24T09:19:58+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-rinvoq-atopic-dermatitis/attachment/33151969262_80181b4028_k/ 2021-08-25T10:29:35+00:00 https://www.pharmaceutical-business-review.com/news/roche-collaboration-licence-agreement-roche/attachment/roche-5-e1629887248429/ 2021-08-26T08:40:51+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-fda-covid-19-booster-dose/attachment/vaccinate-4833616_1280-4/ 2021-08-26T09:23:38+00:00 https://www.pharmaceutical-business-review.com/news/lilly-lycia-lytac-degraders-development/attachment/1440px-eli_lilly_corporate_center_indianapolis_indiana_usa-3/ 2021-08-26T13:32:06+00:00 https://www.pharmaceutical-business-review.com/news/japan-approve-astrazenecas-forxiga/attachment/astrazeneca_hq-27th-aug/ 2021-08-27T07:34:36+00:00 https://www.pharmaceutical-business-review.com/news/inovio-covid-vaccine-brazil/attachment/research-2708/ 2021-08-27T10:44:34+00:00 https://www.pharmaceutical-business-review.com/news/roche-us-tecentriq-breast-cancer/attachment/national-cancer-institute-w2ovh2w2kpo-unsplash-2/ 2021-08-30T09:56:41+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-ucbs-briviact/attachment/syringe-1884784_1280/ 2021-08-31T10:02:26+00:00 https://www.pharmaceutical-business-review.com/news/senhwa-dmc-approval-phase-ii-trial-silmitasertib/attachment/medications-257336_640/ 2021-09-01T08:49:29+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-teva-medincells-schizophrenia/attachment/brain-1787622_1280-2/ 2021-09-01T14:04:46+00:00 https://www.pharmaceutical-business-review.com/news/merck-ridgeback-covid-19-antiviral/attachment/covid-19-4/ 2021-09-02T08:58:58+00:00 https://www.pharmaceutical-business-review.com/news/moderna-submission-covid-19-booster-dose/attachment/coronavirus-4/ 2021-09-02T12:02:01+00:00 https://www.pharmaceutical-business-review.com/news/sobi-takeover-advent-gic/attachment/sobi-2/ 2021-09-03T08:30:19+00:00 https://www.pharmaceutical-business-review.com/news/fda-fast-track-designation-novartis-lna043/attachment/knee/ 2021-09-03T11:07:26+00:00 https://www.pharmaceutical-business-review.com/contractors/tosoh-bioscience/news/50th-anniversary-tskgel/attachment/tskgel-up-sw3000-single-column/ 2021-09-06T08:37:26+00:00 https://www.pharmaceutical-business-review.com/news/reliance-dcgi-approval-phase-i-covid-19-vaccine-trial/attachment/reliance-vaccine/ 2021-09-06T08:51:56+00:00 https://www.pharmaceutical-business-review.com/news/ema-booster-dose-pfizer-biontech/attachment/vaccination/ 2021-09-07T07:12:40+00:00 https://www.pharmaceutical-business-review.com/news/engeneic-covid-vaccine/attachment/vaccine-3/ 2021-09-08T07:30:29+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-genentech-allogeneic-cell-therapies/attachment/cells-0909/ 2021-09-09T04:34:49+00:00 https://www.pharmaceutical-business-review.com/news/aim-application-ampligen-covid-19/attachment/covid-19-pill/ 2021-09-09T08:15:22+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-declines-humanigens-eua-covid-19-lenzilumab/attachment/coronavirus-6557675_640/ 2021-09-10T05:32:22+00:00 https://www.pharmaceutical-business-review.com/news/uks-mhra-sotorasib-lung-cancer/attachment/national-cancer-institute-59pgrokkjpe-unsplash/ 2021-09-13T10:17:04+00:00 https://www.pharmaceutical-business-review.com/news/azurrx-first-wave-bio-229m/attachment/shaking-hands-3091906_1280-7/ 2021-09-14T08:59:20+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-mrna-therapies-firm-translate-bio/attachment/syringe-1884784_1280-2/ 2021-09-15T10:12:46+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-1-4-million-additional-regen-cov-doses/attachment/hand-6276264_1280/ 2021-09-15T16:32:49+00:00 https://www.pharmaceutical-business-review.com/news/lilly-additional-doses-etesevimab-us/attachment/1440px-eli_lilly_corporate_center_indianapolis_indiana_usa-4/ 2021-09-16T09:49:31+00:00 https://www.pharmaceutical-business-review.com/news/hookipa-merck-phase-ii-hb-200-keytruda/attachment/mitosis-3876669_1280-3/ 2021-09-16T12:58:35+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/pharmaceutical-training/attachment/virtual-training/ 2021-09-16T13:33:14+00:00 https://www.pharmaceutical-business-review.com/news/canada-moderna-pfizer-biontechs-covid-19-vaccines/attachment/vaccine-6557415_1280/ 2021-09-17T08:58:16+00:00 https://www.pharmaceutical-business-review.com/news/serum-institute-life-sciences-biocon-biologics-alliance/attachment/medications-257336_1280/ 2021-09-17T15:22:33+00:00 https://www.pharmaceutical-business-review.com/news/grifols-tiancheng-pharmaceutical-1-3bn/attachment/shaking-hands-3091906_1280-8/ 2021-09-20T09:09:34+00:00 https://www.pharmaceutical-business-review.com/suppliers/anatox/attachment/anatox-logo/ 2021-09-20T13:39:51+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-reports-positive-results-for-covid-19-vaccine-trail-in-children-aged-5-to-11-years/attachment/vaccination-1215279_1280/ 2021-09-21T09:03:13+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-samsung-bioepis-biogens-byooviz/attachment/visual-5028090_1280/ 2021-09-21T15:30:25+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-abexxa-biologics-cancer-therapies/attachment/national-cancer-institute-aelk4tn0vli-unsplash/ 2021-09-22T09:31:42+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-pfizer-biontech-covid-19-booster-dose/attachment/injection-5873159_1280/ 2021-09-23T09:07:07+00:00 https://www.pharmaceutical-business-review.com/news/abcellera-everest-medicines-discover-antibody-therapies/attachment/laboratory-3827738_1280/ 2021-09-23T13:34:49+00:00 https://www.pharmaceutical-business-review.com/news/tonix-columbia-university-tailored-covid-19-vaccines/attachment/vaccine-5897391_1280/ 2021-09-24T09:37:57+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-vaxequity-self-amplifying-rna/attachment/original-4/ 2021-09-24T13:59:22+00:00 https://www.pharmaceutical-business-review.com/suppliers/anatox/attachment/anatox-logo2/ 2021-09-24T15:36:10+00:00 https://www.pharmaceutical-business-review.com/products/aiq-tool/attachment/aiq-tool2/ 2021-09-24T15:57:14+00:00 https://www.pharmaceutical-business-review.com/news/who-regeneron-antibody-cocktail-covid-19/attachment/hakan-nural-ycvur2jgfha-unsplash/ 2021-09-27T09:06:56+00:00 https://www.pharmaceutical-business-review.com/products/aiq-tool/attachment/aiq-tool-2/ 2021-09-27T10:42:34+00:00 https://www.pharmaceutical-business-review.com/news/amgen-fda-repatha-paediatric-hefh/attachment/27894408378_38e1cee459_k/ 2021-09-27T14:31:30+00:00 https://www.pharmaceutical-business-review.com/suppliers/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/attachment/a1240241/ 2021-09-28T08:50:59+00:00 https://www.pharmaceutical-business-review.com/suppliers/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/attachment/lts-hauptgebaude-verwaltung-1/ 2021-09-28T08:51:32+00:00 https://www.pharmaceutical-business-review.com/suppliers/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/attachment/210331_map/ 2021-09-28T08:53:18+00:00 https://www.pharmaceutical-business-review.com/suppliers/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/attachment/210705_otf/ 2021-09-28T08:53:40+00:00 https://www.pharmaceutical-business-review.com/suppliers/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/attachment/210705_tts/ 2021-09-28T08:53:58+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-i-trial-mrna-influenza-vaccine/attachment/flu-shot-1719334_1280/ 2021-09-28T09:26:36+00:00 https://www.pharmaceutical-business-review.com/news/incyte-syndax-develop-commercialise-axatilimab/attachment/handshake-3100563_1280/ 2021-09-28T14:12:11+00:00 https://www.pharmaceutical-business-review.com/news/japan-astrazenecas-saphnelo-systemic-lupus-erythematosus/attachment/original-5/ 2021-09-29T09:19:32+00:00 https://www.pharmaceutical-business-review.com/news/union-innovent-develop-market-orismilast/attachment/33151969262_80181b4028_k-2/ 2021-09-30T04:21:29+00:00 https://www.pharmaceutical-business-review.com/news/appili-aipharma-avigan-reeqonus-development/attachment/injection-g496774960_1280/ 2021-09-30T09:37:33+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-acquire-caelum-biosciences/attachment/original-6/ 2021-09-30T15:50:30+00:00 https://www.pharmaceutical-business-review.com/news/trevena-positive-results-of-trv027-covid-19/attachment/corona-gadbedecac_1280/ 2021-10-01T08:43:57+00:00 https://www.pharmaceutical-business-review.com/news/merck-buy-acceleron-pharma-11-5bn/attachment/kenilworth-site-photos-4/ 2021-10-01T10:49:05+00:00 https://www.pharmaceutical-business-review.com/news/kite-fda-tecartus-acute-lymphoblastic-leukemia/attachment/1620px-fda_bldg_51_-_main_entrance_5161374834/ 2021-10-04T11:03:07+00:00 https://www.pharmaceutical-business-review.com/news/australia-agreement-new-covid-19-drug/attachment/medicine-ga0b28755b_1280/ 2021-10-05T08:44:56+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-fda-eua-antibody-cocktail-covid-19/attachment/virus-g90c66212d_1280/ 2021-10-06T06:54:39+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-alexion-concludes-caelum-acquisition/attachment/800px-astrazeneca_hq_in_cambridge_uk/ 2021-10-07T09:07:45+00:00 https://www.pharmaceutical-business-review.com/products/software-driver-development/attachment/anatox-logo2-2/ 2021-10-07T14:26:10+00:00 https://www.pharmaceutical-business-review.com/news/enzolytics-samsung-biologics-therapies-hiv-covid-19/attachment/national-cancer-institute-zeitggtlwzi-unsplash/ 2021-10-08T09:06:12+00:00 https://www.pharmaceutical-business-review.com/news/brii-biosciences-eua-brii-196-brii-198-therapy/attachment/50953231798_30e4eff0b7_k/ 2021-10-11T10:14:06+00:00 https://www.pharmaceutical-business-review.com/news/pacira-buy-flexion-therapeutics/attachment/knee-g13e74aa9f_1280/ 2021-10-12T10:22:24+00:00 https://www.pharmaceutical-business-review.com/news/poseida-takeda-eight-in-vivo-gene-therapy/attachment/cdc-rhcnmh9vlmw-unsplash/ 2021-10-13T09:16:46+00:00 https://www.pharmaceutical-business-review.com/products/aiq-tool/attachment/anatox_aiq-tool_2016_final_web-267e5fc8/ 2021-10-14T09:24:30+00:00 https://www.pharmaceutical-business-review.com/news/fda-ema-accept-novartis-beovu/attachment/diabetic_macular_edema/ 2021-10-14T10:02:25+00:00 https://www.pharmaceutical-business-review.com/news/intellia-sparingvision-develop-ocular-therapies/attachment/eye-gc1c5ed892_1280/ 2021-10-14T12:36:22+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-storm-novel-drug-leads-treat-cancer/attachment/national-cancer-institute-folo2hdmsa4-unsplash-2/ 2021-10-15T05:30:42+00:00 https://www.pharmaceutical-business-review.com/news/silence-hansoh-novel-sirna-therapeutics/attachment/laboratory-ga56586165_1280/ 2021-10-18T12:38:49+00:00 https://www.pharmaceutical-business-review.com/news/us-fdas-jj-covid-19-vaccine-booster/attachment/steven-cornfield-ntvfmrmmxwy-unsplash-2/ 2021-10-18T15:13:24+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-making-sites/attachment/covid-19-vaccine-gd7a2b75c8_1280/ 2021-10-19T09:45:11+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-oyster-point-pharmas-nasal-spray/attachment/people-g34c941786_1280/ 2021-10-19T15:32:49+00:00 https://www.pharmaceutical-business-review.com/news/moleculin-mhra-phase-ia-wp1122-covid-19/attachment/coronavirus-g7f1f35cd5_1280/ 2021-10-20T09:38:56+00:00 https://www.pharmaceutical-business-review.com/news/amgen-biotechnology-firm-teneobio/attachment/grounds_to_051/ 2021-10-20T15:46:39+00:00 https://www.pharmaceutical-business-review.com/news/beigenes-brukinsa-mantle-cell-lymphoma/attachment/nodular_mantle_cell_lymphoma_-_high_power_view_-_by_gabriel_caponetti/ 2021-10-21T11:26:38+00:00 https://www.pharmaceutical-business-review.com/news/atreca-gates-mri-antibody-malaria-prevention/attachment/malaria_parasite_connecting_to_human_red_blood_cell_34034143483/ 2021-10-22T09:50:39+00:00 https://www.pharmaceutical-business-review.com/news/ec-keytruda-chemotherapy-combination-tnbc/attachment/keytruda-100mg-4ml-vial-and-carton-6/ 2021-10-25T11:10:33+00:00 https://www.pharmaceutical-business-review.com/news/emas-rolling-review-molnupiravir-covid-19/attachment/kenilworth-site-photos-5/ 2021-10-26T11:27:43+00:00 https://www.pharmaceutical-business-review.com/news/vertex-mammoth-in-vivo-gene-editing-therapies/attachment/dna-g142f71882_1280/ 2021-10-27T09:08:44+00:00 https://www.pharmaceutical-business-review.com/news/teva-modag-drug-candidates-neurodegenerative/attachment/1457px-msa_asynuclein/ 2021-10-27T13:59:28+00:00 https://www.pharmaceutical-business-review.com/news/takeda-gammadelta-allogeneic-cell-therapies/attachment/shaking-hands-gcbca28405_1280/ 2021-10-28T09:36:20+00:00